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Non-melanoma skin cancer (NMSC) is the most common cancer in the United States. 
The absence of selective toxicity is the major problem associated with chemotherapeutic and 
radiation therapy for NMSCs. The goal of the present study was to determine the molecular 
mechanism of action of a potential selective treatment for NMSC, arachidonoyl ethanolamide 
[AEA, (also known as anandamide)]. Our research revealed that two factors provide AEA with 
its selective toxicity, the elevated cyclooxygenase-2 (COX-2) levels and the activated 
endoplasmic reticulum (ER) stress signaling in tumorigenic keratinocytes which differentiates 
them from normal cells. COX-2 is an enzyme that promotes tumor development by synthesizing 
E-series prostaglandins (PGs) that promote cell proliferation. Selective inhibition of COX-2 is 
successfully used in treatment of skin cancer. Rather than inhibiting COX-2, the novel approach 
of exploiting the overexpression of COX-2 was utilized. In tumorigenic keratinocytes, AEA was 
metabolized by COX-2 to cytotoxic J-series prostaglandin-ethanolamides (PGJ2-EAs) that are 
 
 
 
 
structurally distinct from arachidonic acid (AA)-derived J-series PGs. This data is novel and to 
the candidate’s knowledge, this is the first report showing that PGJ2-EAs are produced as an 
AEA metabolic product. Furthermore, several studies showed that J-series PGs derived from AA 
induce oxidative stress, ER stress and apoptosis. Therefore, the candidate hypothesized that AEA 
is metabolized to PGJ2-EAs, which induce oxidative stress followed by ER stress and ultimately 
apoptosis as a novel mechanism of action of AEA. The candidate also took advantage of 
evidence, which shows that ER stress is moderately elevated in tumor cells when compared to 
normal cells. Under these circumstances, the exposure of cells to agents that induce additional 
stress is expected to cause overwhelming ER stress and subsequently apoptosis selectively in 
tumor cells. Indeed, the candidate determined that AEA induced ER stress-mediated apoptosis in 
COX-2 expressing tumor cells but not in normal cells. Hence, the present study provides an 
alternative strategy for topical treatment of NMSCs that will be selectively cytotoxic to cancer 
cells but not detrimental to normal, healthy surrounding cells. 
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CHAPTER ONE: GENERAL INTRODUCTION 
1.1. Cancer 
 Cancer is a disease that is characterized by uncontrolled proliferation of abnormal cells. 
Cancer typically develops as a consequence of genetic and epigenetic alterations of genes that 
regulate cell growth, cell death and DNA repair. The first stage in tumor development is 
initiation, during which irreversible DNA damage occurs in the genetic sequence of tumor 
promoter proteins or oncogenes. In the second stage of tumoregenesis, promotion, continuous 
exposure to agents that promote proliferation and/or inflammation causes clonal expansion of the 
initiated cell and more extensive DNA damage. In the final and irreversible stage of tumor 
formation, progression, cells transition from benign to malignant tumors and exhibit autonomous 
growth as well as the ability to metastasize. These events culminate in the formation of tumors 
which are diagnosed in more than 500,000 individuals each year (Weinburg, 2013).       
1.1.1. Non Melanoma Skin Cancer 
 Skin cancer is the most common cancer in the United States. There are two major 
categories of skin cancer: melanoma, which originates from melanocytes, and non- melanoma 
skin cancer (NMSC) which originates from either squamous cells (squamous cell carcinoma) or 
basal cells (basal cell carcinoma) (Madan et al., 2010). Non melanoma skin cancers (NMSCs) 
comprise the most frequently occurring forms of skin cancer. According to the skin cancer 
foundation's most recent estimates, “More than two million people in the US are developing over 
3.5 million NMSCs  every year” (Skin Cancer Foundation, 2012).  Although death from these 
cancers is uncommon, NMSCs are associated with substantial annual health care costs. The 
estimated cost in 2004 was $1.4 billion direct costs and $76.8 million indirect costs (Bickers et 
al., 2006;Guy and Ekwueme, 2011). The incidence of NMSCs has been increasing rapidly in the 
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past few decades probably due to increased sun and UV light exposure, increased outdoors 
activities, and/or ozone depletion (Gloster, Jr. and Brodland, 1996;Armstrong and Kricker, 
2001;Diepgen and Mahler, 2002).  
1.2. Role of cyclooxygenase-2 (COX-2) in NMSCs 
 It has been reported that UV irradiation induces COX-2 expression in the skin (Fischer et 
al., 1999). COX-2 is the rate-limiting enzyme for the production of prostaglandins (PGs) from 
arachidonic acid (AA) (Figure 1.1) (Pentland, 1998). AA is liberated from membrane 
phospholipids by the enzyme phospholipase A2. COX-2 then oxygenates AA to PGH2 followed 
by its metabolism by PG synthase-E, -F2α, or -D to PGE2, PGF2α, and PGD2, respectively. PGD2 
is then dehydrated to J-series PGs.  Increasing evidence points to a role for COX-2 and its 
products, notably PGE2, in the development of NMSCs. Compared to normal keratinocytes, 
NMSCs typically overexpress COX-2, with elevated levels of COX-2 correlating with the 
severity of skin tumors (Buckman et al., 1998;Athar et al., 2000;Spallone et al., 2011). COX-2 
and PGE2 promote keratinocyte proliferation, angiogenesis, and cell migration by increasing the 
expression of oncogenes, cytokines and growth factors (Rundhaug et al., 2007;Rundhaug et al., 
2011).  
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Figure 1.1: Arachidonic acid metabolism by COX-2  
AA is liberated from membrane phospholipids by cytosolic phospholipase A2. COX-2 then 
oxygenates AA to PGH2 followed by its metabolism by PG synthase-E, -F2α, or -D to PGE2, 
PGF2α, and PGD2, respectively. PGD2 is then dehydrated to J-series PGs (PGJ2, Δ12,14 
Prostaglandin J2 and 15 deoxy Δ12,14Prostaglandin J2). 
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1.3. Anti-tumorigenic effect of cyclopentenone J-series prostaglandins  
 Contrary to the pro-proliferative E-type PGs, D-type and J-type PGs induce cell death. 
Three J-series prostaglandins exist (i) PGJ2, (ii) Δ12 PGJ2 and (iii) 15-deoxyΔ12,14 PGJ2 (15d-
PGJ2) (see figure 1.1). Previous studies in our lab and others revealed that J-series PGs induce 
apoptosis (Clay et al., 1999;Van Dross, 2009;Wang and Mak, 2011;Kuc et al., 2012). In contrast, 
Millan et al. found that DMBA/TPA-mediated skin tumorigenesis was enhanced when 15d-PGJ2 
was applied topically during the tumor initiation phase (Millan et al., 2006). This finding was 
likely due to the concentration of J-series PGs used in the study as it has been found that low 
concentrations of 15d-PGJ2 are cytoprotective while high concentrations are pro-apoptotic 
(Levonen et al., 2001). 
 Numerous studies have determined that J-series PG-mediated apoptosis is regulated by its 
ability to promote reactive oxygen species (ROS) production (Kondo et al., 2001;Chen et al., 
2005). The unique receptor-independent biological effects of the J-series PGs are proposed to be 
due to the presence of a highly reactive α, β-unsaturated carbonyl group in the cyclopentenone 
ring that can covalently interact via Michael addition reaction with nucleophiles such as free 
sulfhydryls of cysteine residues in cellular proteins. J-series PGs induce oxidative stress by 
covalently binding to sulfhydryl-containing glutathione (GSH) and other proteins that regulate 
cellular redox status (Kondo et al., 2001;Uchida and Shibata, 2008). In addition, J-series PG-
induced oxidative stress is also mediated by an increase in reactive molecules including 4-
hydroxy-2-nonenal (HNE) and acrolein (Kondo et al., 2001).     
1.4. Reactive oxygen species (ROS)  
Reactive oxygen species are reactive molecules containing oxygen such as superoxide 
anion (O2-), hydrogen peroxide (H2O2), and hydroxyl radical (OH.). In eukaryotic cells, ROS can 
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be generated by many organelles including mitochondria and endoplasmic reticulum (ER). 
Mitochondria are the major source of ROS in the cell. During oxidative phosphorylation in the 
mitochondria, a small fraction of electrons from the electron transport chain (ETC) are 
transferred to O2 to generate superoxide anion which then can give rise to other ROS (Cadenas 
and Davies, 2000).  The endoplasmic reticulum is also considered an important source of ROS in 
the cell. During oxidative protein folding, ER oxidoreductase 1 (Ero1) accepts electrons from 
protein disulfide isomerase (PDI) and transfers them to molecular oxygen (O2) to produce H2O2, 
the major ROS produced in the ER lumen (Cao and Kaufman, 2014). ROS are second 
messengers in signal transduction. A low concentration of ROS is required for many 
physiological functions such as immune defense against pathogens, induction of mitogenic 
response and maintaining cellular homeostasis (Finkel, 1998;Droge, 2002). Under normal 
conditions, the ROS concentration is maintained within strict physiological limits by enzymatic 
and non-enzymatic antioxidant defense systems. The enzymatic components of antioxidant 
system include glutathione reductase, glutathione peroxidase, catalase, superoxide dismutase, etc 
(Mates et al., 2012). The most important endogenous non-enzyme antioxidant is Glutathione 
(GSH). GSH is a thiol containing compound, which is abundant in cytosol, nucleus and 
mitochondria and maintains the intracellular redox balance. GSH is a cofactor for detoxifying 
enzymes such as GSH peroxidase and GSH transferase. GSH also acts as a scavenger of HO. and 
singlet oxygen and detoxifies H2O2 and lipid peroxides (Masella et al., 2005;Kaur et al., 2014).  
Tipping the balance towards prooxidants favors the production of ROS and oxidative stress.  
High concentrations of ROS cause oxidative damage to cellular proteins, lipids and DNA (Kaur 
et al., 2014). 
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1.4.1. Oxidative stress and cancer 
Cancer cells are characterized by an altered redox environment. They produce higher levels 
of ROS compared to normal cells. Relatively high ROS production in cancer cells activates 
signaling pathways that regulate cell proliferation, survival, angiogenesis and metastasis 
(Nourazarian et al., 2014). However, excessive levels of ROS induce cell cycle arrest and cell 
death. Hence, this unique redox status of cancer cells can be exploited to selectively target cancer 
cells. Cancer can be treated by either dampening ROS levels below the level, which is required 
for cell proliferation or by promoting ROS production and, therefore, causing lethal oxidative 
damage (Glasauer and Chandel, 2014).      
1.5. Endoplasmic reticulum stress 
 ER stress occurs when the cell’s capacity to fold proteins is exceeded by the protein folding 
load. ER stress results in dysregulation of protein folding, accumulation of unfolded proteins and 
activation of the unfolded protein response (UPR) (Holcik and Sonenberg, 2005). UPR is an 
integrated intracellular signal transduction pathway mediated by three ER-resident stress sensors: 
double-stranded RNA-activated protein kinase (PKR)-like endoplasmic reticulum kinase 
(PERK), activating transcription factor-6 (ATF6), and inositol requiring kinase-1 (IRE1) (Lin et 
al., 2008;Chakrabarti et al., 2011).  Activation of the three proximal sensors is regulated by a 
member of heat shock protein-70 (HSP-70) family of chaperones, BiP/GRP78. Normally, each 
of these sensors is bound to GRP78 in the lumen of the ER (Figure 1.2). However, upon 
accumulation of unfolded and misfolded proteins, BiP dissociates from these sensors. 
Dissociated PERK homodimerizes and becomes autophosphorylated. Phospho-PERK (P-PERK) 
then phosphorylates the α subunit of eukaryotic initiation factor 2 (eIF2α), resulting in a global 
reduction in translation and a switch to translation of proteins required for cell survival under ER 
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stress such as activated transcription factor 4 (ATF4) (Marciniak and Ron, 2006;Shore et al., 
2011). ATF4 drives the expression of pro-survival genes encoding proteins involved in amino 
acid biosynthesis and transport as well as antioxidants (Harding et al., 2003;Holcik and 
Sonenberg, 2005;Chakrabarti et al., 2011).  Upon dissociation from BiP, pATF6 (90 kDa) 
translocates to the Golgi compartment where it is processed to its active form through cleavage 
by site-1 and site-2 proteases (S1P and S2P). The 50-kDa cytosolic fragment migrates to the 
nucleus and activates transcription of target genes encoding proteins required for alleviation of 
ER stress such as ER resident molecular chaperones and the ER associated degradation (ERAD) 
machinery (Ye et al., 2000;Nadanaka et al., 2004;Shen and Prywes, 2005;Zhang and Kaufman, 
2008). Dissociation of BiP from IRE1 leads to homodimerization and trans-autophosphorylation. 
Activated IRE1 functions as endoribonuclease to remove a small intron from X-box binding 
protein1 (XBP1) mRNA. Spliced XBP1 mRNA encodes a transcription factor that increases the 
expression of genes encoding enzymes that facilitate protein folding or degradation. ER 
homeostasis is re-established through the activation of UPR. However, when ER stress is too 
severe or prolonged, the pro-survival function of the UPR turns into a toxic signal, which is 
predominantly executed by mitochondrial apoptosis (Zhang and Kaufman, 2008;Chakrabarti et 
al., 2011).  
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Figure 1.2: ER stress signaling pathway 
ER stress signaling is principally mediated by ER-resident stress sensors: PERK, ATF6 and 
IRE1, which are maintained in an inactive state by binding to the ER chaperone BiP. 
Accumulation of unfolded proteins in the ER leads to dissociation of BiP from these sensors and 
initiation of ER stress signal transduction. Dissociated PERK homodimerizes and becomes 
autophosphorylated. Phospho PERK phosphorylates eIF2α leading to a generalized inhibition of 
translation initiation with preferential translation of the transcription factor, ATF4. ATF6 
translocates to the Golgi apparatus following activation where it is cleaved into an active 
transcription factor. Activated IRE1 functions as endoribonuclease which cleaves XBP1 mRNA 
to spliced XBP1(S-XPB1) mRNA which encodes for a transcription factor. Under mild ER 
stress, the ATF4, ATF6, and XBP1 transcription factors increase the expression of ER resident 
chaperones and ERAD machinery proteins that are required to alleviate ER stress. During 
extensive ER stress, CHOP10 expression is increased resulting in apoptosis.  
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1.5.1. ER stress-induced apoptosis 
 The predominant trigger of ER stress-mediated apoptosis is C/EBP homologous protein 
(CHOP10), also known as growth arrest and DNA damage-inducible gene 153 (GADD153). 
CHOP10 transcription is regulated at least by four cis-acting elements, AARE1, AARE2, 
ERSE1, and ERSE2. The three transcription factors that are activated in response to ER stress 
(ATF4, P50-ATF6, and S-XBP1) are known to transactivate CHOP10 (Figure 1.2). ATF4 binds 
to and activates AARE1 and AARE2. Both p50-ATF6 and XBP1 bind to and activate ERSE1 
and ERSE2 (Oyadomari and Mori, 2004). CHOP10 is a transcription factor that regulates the 
expression of pro- and anti-apoptotic genes. Under conditions of prolonged or high level 
CHOP10 expression, GADD34 is expressed and interacts with protein phosphatase 1 (PP1) to 
dephosphorylate P-eIF2α. This leads to a restoration in global protein translation and an increase 
in the expression of pro-apoptotic genes including death receptor 5 (DR5) (Yagi et al., 
2003;Marciniak et al., 2004;Lim et al., 2009). In addition CHOP10 represses the transactivation 
of anti-apoptotic genes including Bcl-2 (McCullough et al., 2001) thus creating conditions, 
which favor apoptosis. 
1.5.2. ER stress as an anticancer strategy 
 It is well established that tumor cells are under stress due primarily to the increased levels 
of hypoxia and decreased levels of glucose (Luo et al., 2009).  Consequently, limited energy is 
available while the rate of protein processing for cell proliferation is high. As an adaptive 
response, the UPR is activated to counteract the ongoing stress by accommodating the increased 
protein folding load (Luo et al., 2009;Hsiao et al., 2009). It is important to note that ER stress is 
generally inactive in most normal cells (except those with a high demand on the ER such as 
insulin secreting pancreatic cells and antibody producing B-cells) (Healy et al., 2009). There are 
 
 
12 
 
two approaches to target ER stress. One approach is to inhibit the ER stress so tumor cells can no 
longer accommodate the increased protein folding load, thereby leading to cell death. However, 
the risk exists that the anticancer drug in question might actually block ER stress-mediated 
apoptosis. The second approach is to expose the tumor cells to overwhelming ER stress, which 
will drive the cells beyond their capacity to regulate the stress and activate cell death pathway 
(Healy et al., 2009;Verfaillie et al., 2010;Johnson et al., 2011). This difference in the endogenous 
ER stress levels allows one to induce cytotoxic ER stress in tumor but not normal cells using ER 
stress inducing agents. As such, therapeutic benefit can result from targeting this signaling 
pathway. 
 Since J-series PG-induced apoptosis can be mediated by activation of the UPR (Takahashi 
et al., 1998;Saito et al., 2003;Weber et al., 2004;Chambers et al., 2007) and anandamide is 
metabolized by COX-2 in tumorigenic keratinocytes to J-series PGs, it is plausible that AEA 
produces overwhelming stress driving the tumor but not normal cells toward apoptosis.  
1.6. Endogenous cannabinoids (endocannabinoids) 
 Endocannabinoids are neuromodulatory lipids that regulate physiologic and pathologic 
processes including appetite, mood, learning/memory, pain sensation and inflammation by 
activating the endogenous cannabinoid (endocannabinoid) system (ECS). ECS includes (i) 
endocannabinoids, which mimic many of the effects of phytocannabinoids such as Δ9 
tetrahydrocannabinol (Δ9THC), the active ingredient of Cannabis sativa (marijuana), (ii) 
molecular transporters, (iii) cannabinoid receptors; cannabinoid receptor 1 (CB1R) and 
cannabinoid receptor 2 (CB2R) and (iv) the enzymes involved in cannabinoid synthesis and 
degradation (Bisogno et al., 2005). 
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1.6.1. Anandamide 
 Anandamide (aka arachidonyl ethanolamide, AEA) is a prototype endocannabinoid. AEA 
binds CB1 and CB2 receptors and then is transported into cells via the anandamide membrane 
transporter (AMT). The action of AEA is then terminated by fatty acid amide hydrolase (FAAH) 
(Cravatt et al., 1996). Cannabinoid receptors seem to play an important role in the regulation of 
the anticancer activity of AEA. Several studies showed that AEA inhibits the proliferation of 
breast and prostate cancers in a CB1 receptor-dependent manner (De et al., 1998;Melck et al., 
1999;Melck et al., 2000;Nithipatikom et al., 2011). However, studies conducted in our lab and 
others revealed that AEA-induced cell death can occur by receptor-independent pathways 
(Patsos et al., 2010;Kuc et al., 2012).   
1.6.1.1. Anandamide metabolism 
 Fatty acid amide hydrolase (FAAH) hydrolyzes AEA to arachidonic acid (AA) plus 
ethanolamine (Deutsch and Chin, 1993). Consequently, FAAH terminates the biological activity 
of AEA (Bifulco et al., 2004;Siegmund et al., 2006;Kuc et al., 2012). Because AEA has an 
unmodified arachidonate backbone (Figure 1.3), AEA is also susceptible to oxidative 
metabolism by oxygenases that metabolize AA such as lipoxygenase (LOX), cytochrome P450 
and cyclooxygenases (COX). For example, 12- and 15-LOX metabolize AEA to 12(S)-hydroxy-
AEA [12(S) HAEA] and 15-HAEA (Edgemond et al., 1998). CYP2J2, CYP2B6 and CYP2D6 
were reported to metabolize AEA to epoxyeicosatrienoic acids ethanolamide (EET-EA) and 
hydroxyeicosatetraenoic acid ethanolamide (HETE-EA) (Snider et al., 2009;Sridar et al., 
2011;McDougle et al., 2014). In addition, COX-2 metabolizes AEA to prostaglandin-
ethanolamides (PG-EAs) (Figure 1.4), including PGH2-EA, which is then metabolized to PG-
EAs of E, F2α, and D by selective prostaglandin synthases (Yu et al., 1997;Kozak et al., 2002a). 
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Our lab reported, for the first time, that ethanolamide conjugated J-series PGs are also produced 
from anandamide (Figure 1.4) (Soliman et al., 2014). Studies conducted by Kozak et al., 2001 
reported that the PG-EAs produced from AEA are more metabolically stable than free acid PGs 
and also suggested that these molecules might have unique activity (Kozak et al., 2001). 
However, the biological activity of many of the metabolic products of AEA is still unknown. 
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Figure 1.3: Chemical structure of Arachidonic acid and Anandamide 
The chemical structure of AA and AEA is obtained from reported studies (Wiley et al., 2006) . 
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Figure 1.4: Metabolism of Anandamide by COX-2 
COX-2 metabolizes AEA to PGH2-ethanolamide (PGH2-EA), which is then metabolized to 
PGD2-EA, PGE2-EA, and PGF2α-EA by selective prostaglandin synthases. PGD2-EA is then 
dehydrated to PGJ2-EA, Δ12PGJ2, and 15-deoxyΔ12,14PGJ2-EA. 
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1.7. Specific Aims  
 The antiproliferative effect of anandamide (aka arachidonyl ethanolamide, AEA) on 
tumorigenic keratinocytes (JWF2) is dependent upon the metabolism of AEA by 
cyclooxygenase-2 (COX-2) to PGJ-EAs (Van Dross, 2009;Soliman et al., 2014). In addition, 
oxidative stress mediates AEA-induced apoptosis (Kuc et al., 2012). However, a detailed 
identification of the signaling molecules and pathways involved in AEA-induced apoptosis in 
tumorigenic keratinocytes was needed. To begin to understand how AEA causes apoptosis, two 
important signal transduction pathways, ER stress and oxidative stress, were examined. It is well 
established that ER stress and oxidative stress are key regulators of cell death in a variety of 
tumor cell types.  Several cannabinoids and AA-derived, J-series prostaglandins induce oxidative 
stress, ER stress and apoptosis (Chambers et al., 2007;Su et al., 2008). Therefore, the present 
study hypothesized that the J-series metabolic products of AEA initiated ER stress-induced 
apoptosis through the induction of oxidative stress. Furthermore, since our previous data 
indicated that AEA-induced cell death did not require cannabinoid receptor activation we 
hypothesized that oxidative stress, ER stress and apoptosis would also occur independent of 
these receptors. To examine these hypotheses, the following Specific Aims were developed.  
Specific Aim 1  
 Studies in Specific Aim 1 determined the role of COX-2, J-series prostaglandins, and ER 
stress in AEA-induced apoptosis.    
Rationale:  
 AEA causes cell death in a variety of tumor cell lines. AEA-induced cell death was 
controlled by COX-2 in colon and skin cancer cells (Patsos et al., 2010;Kuc et al., 2012).  COX-
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2 metabolized AEA to PGE2-EA, PGF2α-EA and PGD2-EA.  J-series prostaglandins were also 
found to be metabolic products of COX-2 (Van Dross, 2009).  In addition, J-series 
prostaglandin-induced cell death was mediated by ER stress.  Hence, the role of COX-2, J-series 
prostaglandins and ER stress in AEA-induced apoptosis was examined by addressing the 
following questions:  
1- Does AEA activate the apoptotic ER stress response in tumorigenic keratinocytes?  
2- Is apoptotic ER stress signaling required for AEA-induced apoptosis in tumorigenic 
keratinocytes? 
3- Is COX required for AEA-induced ER stress-apoptosis? 
4- What is the identity of the J-series prostaglandins that are derived from AEA? 
5- Is 15d-PGJ2-EA required for AEA-induced ER stress-apoptosis?   
Specific Aim 2  
 Studies in Specific Aim 2 determined if oxidative stress was required for AEA-induced ER 
stress-apoptosis. In addition, the role of CB1R and CB2R in AEA-mediated oxidative stress, ER 
stress and apoptosis was examined. 
Rationale:  
Cancer cells produce relatively high levels of ROS, which can activate pro-survival signal 
transduction pathways. Excessive ROS production may cause irreversible oxidative damage that 
leads to apoptosis in cancer cells (Mates et al., 2012;Glasauer and Chandel, 2014). Oxidative 
stress was required for AEA-induced apoptosis in tumorigenic keratinocytes (Kuc et al., 2012). 
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Also, AA-derived J-series PGs caused cell death by generating excessive oxidative stress.  
Oxidative stress induced by the J-series prostaglandins is mediated by a decrease in GSH and an 
increase in ROS (Kondo et al., 2001;Kondo et al., 2002;Uchida and Shibata, 2008). In addition, 
oxidative stress is an important initiator of endoplasmic reticulum (ER) stress (Cao and 
Kaufman, 2014). The ER is an organelle in which oxidative protein folding occurs, therefore 
alterations in redox status affect ER homeostasis, protein folding, and ER stress-apoptosis 
(Malhotra and Kaufman, 2007;Tabas and Ron, 2011). The structure of J-series PG ethanolamides 
is similar to AA-derived J-series prostaglandins therefore these molecules may exhibit similar 
properties. In addition, AEA-mediated cell death occurs through cannabinoid receptor-dependent 
and -independent pathways.  Therefore, we evaluated the role of oxidative stress and the 
cannabinoid receptors in AEA-induced ER stress-apoptosis by examining the following 
questions: 
1- Is oxidative stress required for AEA-induced ER stress-apoptosis?  
2- What is the mechanism by which AEA induces oxidative stress? 
3- Is the activation of endocannabinoid receptors CB1 or CB2 required for AEA-induced 
apoptosis? 
4- Is the activation of endocannabinoid receptors CB1 or CB2 required for AEA-induced 
oxidative and ER stress?  
 
 
 
CHAPTER TWO: MATERIALS AND METHODS 
2.1. Antibodies and reagents 
 AEA, 15-deoxy-∆12,14 PGJ2, PGD2-EA, AM251, AM630 and PGD2 ELISA kits 
were purchased from Cayman Chemical Company (Ann Arbor, MI). 15-deoxy-∆12,14 PGJ2 
ELISA kits were purchased from Assay Designs (Ann Arbor, MI). Anti-COX-2-TRITC, goat 
anti-lamin B1 and anti-COX-2 and rabbit anti-CHOP10 were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). Rabbit anti-FAAH, anti-P-PERK, anti-t-PERK, anti-P-eIF2α, 
anti-t-eIF2a, and anti-t-IRE1 were obtained from Cell Signaling Technology (Beverley, MA). 
Mouse anti-full length (FL) caspase-3 was from Invitrogen (Carlsbad, CA) and anti-GAPDH was 
from Trevigen (Gaithersburg, MD). Rabbit anti-P-IRE1 was purchased from Abcam 
(Cambridge, MA). Anti-rabbit Alexafluor 488 and anti-goat Alexafluor 555 were from 
Invitrogen (Grand Island, NY) while anti-goat Alexafluor 647 was from Jackson 
Immunoresearch (West Grove, PA).  Anti-goat IRDye 800CW, anti-rabbit 800CW, anti-mouse 
800CW, and anti-mouse 680RD were from Li-cor Biosciences (Lincoln, Nebraska). Rabbit anti-
H-PGDS and anti-L-PGDS were purchased from Cayman Chemical Company (Ann Arbor, MI). 
N-Acetyl Cysteine, and Trolox were purchased from Sigma-Aldrich (St. Louis, MO). Anti-ATF6 
(TO 13/14) was a gift from Dr. Allen Volchuk, Toronto General Research Institute.  
2.2. Cell culture 
 The murine squamous carcinoma cell line JWF2 (a kind gift from Dr. Susan 
Fischer; MD Anderson Cancer Center, Smithville, TX) was cultured in Eagle’s minimal essential 
medium (US Biological) containing 5% heat-inactivated fetal bovine serum, penicillin (100 
mg/ml), streptomycin (100 mg/ml), nonessential amino acids, and glutamine. Human 
keratinocytes, HaCaT (Cell Line Service, Germany) and human colorectal cancer cells, HCA7
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 (Sigma-Aldrich, MO) were cultured in Dulbecco’s minimal essential media (Invitrogen) 
containing 10% heat-inactivated FBS, penicillin (100 mg/mL), streptomycin (100 mg/mL), and 
sodium pyruvate (1mM). HT29 cells (a kind gift from Dr. Jean-Luc Scemama, Department of 
Biology, East Carolina University) were cultured in McCoy’s 5A media (Sigma-Aldrich, MO) 
containing 10% heat-inactivated fetal bovine serum, penicillin (100 mg/ml), streptomycin (100 
mg/ml).  
2.3. Liquid Chromatography-Mass Spectrometry (LC-MS) 
Prostaglandins were extracted from acidified cell culture medium using solid phase 
extraction (SPE).  After the sample was applied to the equilibrated cartridge, the packing bed 
was washed with ultrapure deionized water, followed by 15% acetonitrile and 100% hexane.  
Prostaglandins were eluted in 100% acetonitrile.  Extracted prostaglandins were evaporated to 
dryness under a stream of nitrogen gas and reconstituted in 10 µL of acetonitrile.  
LC-MS was performed on a Waters Acquity Ultra-High Performance Liquid 
Chromatograph paired with a Micromass Quadrupole/Time-of-Flight Mass Spectrometer 
equipped with an Electrospray Ionization (ESI) source (Milford, MA).  The LC was equipped 
with an Acquity C8 column (2.1 mm i.d., 100 mm length, particle diameter 1.7 µM).  Mobile 
phase composition was solvent A (90/10 v/v water/acetonitrile) and solvent B (100% 
acetonitrile).  The gradient began at 65% A/35% B; it was lowered to 50% at 5%/minute, then to 
35% A at 7.5%/minute at a constant flow rate of 0.4 mL/minute.  Eluent was introduced into the 
ESI source, which is heated to 275°C, using a cone gas (nitrogen) flow rate of 10 L/hr.  Inside 
the ESI source, heated nitrogen gas (120°C, flow rate 500 L/hr.) aided in desolvation.  The ESI 
source was operated in negative ion mode.  For LC-MS/MS experiments, parent ions were mass-
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selected in the quadrupole and were subjected to collision-induced dissociation (CID) in the 
hexapole collision cell.  Collision energy was 25 eV and argon was the collision gas. 
2.4. Transfections and luciferase assays 
 HaCaT cells were cultured in chamber slides and transfected with human COX-2 cDNA 
in pcDNA6.1 (pcDNA6.1-h-COX-2) or pcDNA6.1 with no insert (empty vector) using 
Lipofectamine LTX and Plus Reagent (Invitrogen).  For luciferase assays, HaCaT cells were co-
transfected with the ER stress responsive element (ERSE) luciferase reporter and the Renilla 
luciferase expression plasmid (Qiagen Sciences). The total DNA concentration transfected into 
HaCaT cells was equivalent. Luciferase activity was determined using the Dual-Luciferase 
Reporter Assay System (Promega). 
2.5. XBP splicing assay 
 Reverse-transcriptase polymerase chain reaction (RT-PCR) was carried out using 
standard procedures (Sambrook et al., 1989). JWF2 cells were treated as indicated, RNA 
isolated with Trizol Reagent and 1 µg of total RNA from each sample treated with DNase I 
followed by first strand synthesis with MMLV reverse transcriptase (Invitrogen, Carlsbad, CA). 
XBP1 forward 5'-GAACCAGGAGTTAAGAACACG-3' and reverse 5'-
AGGCAACAGTGTCAGAGTCC-3' PCR primers (Samali et al., 2010) amplify both unspliced 
(205bp) and spliced (179bp) XBP1. GAPDH forward and reverse primers are 5'-
GTCTACTGGTGTCTTCACCA-3' and 5'-GTGGCAGTGATGGCATGGAC-3' (Van Dross et 
al., 2007) , respectively.  PCR products were resolved on a 3% MetaPhor agarose gel (Cambrex 
BioScience).  
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2.6. Western blot analysis 
 Western blot analysis was conducted as described previously (Van Dross, 2009). JWF2 
cells were plated in 100 mm tissue culture plates for 48 hours and treated as indicated in serum-
free culture medium. Cells were washed twice with phosphate buffer saline (PBS) then 100 μl 
triton lysis buffer (TLB) (1% Triton, 25mM Tris pH 7.4, 150mM NaCl + protease phosphtase 
inhibitors mix) was added. Whole cell lysate was centrifuged at 14,000 rpm (20,000 x g) for 20 
min and the supernatant was used for the determination of protein concentration using BCA 
reagents (Thermo Fisher Scientific Inc., IL, USA). Equal concentrations of each sample were 
loaded on to SDS–PAGE gels and protein bands transferred to nitrocellulose membranes 
(BioRad, Hercules, CA) in the semi-dry transfer cell TRANS-BLOTSD (Bio-Rad Laboratories, 
Hercules, CA) using transfer buffer (containing 230 mM glycine, 25mM Tris, 0.7 mM SDS, 
20% methanol) at 26 volts for one hour. Nonspecific binding sites on the membranes were 
blocked at room temperature using Odyssey blocking buffer (LI-COR Biosciences, Lincoln, 
NE) for two hours. Membranes were then incubated with the indicated primary antibodies 
overnight and the appropriate secondary antibody for one hour. Protein bands were visualized 
using the Li-cor system and digitized images quantified using Image-J software. 
2.7. Immunofluorescence 
 Cells were treated as indicated, fixed with methanol, incubated with permeabilization 
buffer (0.1% Triton X-100 in 1xPBS) for 10 minutes, and then blocked with blocking buffer 
(1X PBS + 3% FBS + 0.5% Tween20) for 1 hour. The blocked cells were then incubated with 
the indicated primary antibodies and the appropriate immunofluorescence-tagged secondary 
antibodies. Images were acquired and analyzed by confocal laser microscopy (ZEISS LSM 510 
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confocal microscope system). Fluorescence intensity was quantified using Zen Lite 2011 
software. 
2.8. D- and J-series prostaglandin ELISA assays 
 The culture medium from agent-treated JWF2 cells was collected and D- and J-series 
prostaglandins measured with ELISA kits as described by the manufacturers.  
2.9. MTS cell viability assay  
JWF2 cells were plated in 96-well plates and cultured for 48 h. Media containing the 
appropriate concentration of different agents were added to the cells for the indicated time. 20 µl 
MTS reagent (Promega, Madison, WI) was then added to each well as directed by the 
manufacturer and absorbance measured at 495 nm. 
2.10. Oxidative stress measurement 
The oxidative stress in JWF2 cells was measured by chloromethyl-2',7' 
dichlorodihydrofluorescein diacetate (CM-H2DCFDA) staining. Cells were treated with 5μM 
CM-H2DCFDA (Molecular Probes, Invitrogen) in phenol red-free, serum-free medium for 30 
min and then treated with the appropriate drug for the indicated time.  Cells were then 
trypsinized and suspended in PBS.  DCF fluorescence was measured using an Accuri C6 flow 
cytometer (BD Accuri Cytometers, Ann Arbor, MI, USA) at an excitation wavelength of 488 and 
a 533±30-nm emission filter. 
2.11. Flow cytometry analysis of P-eIF2α 
Treated cells were trypsinized, resuspended in PBS, centrifuged, and the cell pellet 
reconstituted in 4% formaldehyde in PBS. The cells were then fixed for 10 min at 370C and 
samples permeabilized with methanol (the final concentration is 90% methanol). Cells were then 
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washed using incubation buffer, counted, aliquoted (1*106 cells/sample), and blocked in 
incubation buffer.  Next, JWF2 cells were exposed to P-eIF2α antibody followed by Alexafluor 
555 secondary antibody (Life technologies, Invitrogen).  The mean fluorescence of 10000 life 
events was detected with Accuri C6 flow cytometer (BD Accuri Cytometers, Ann Arbor, MI, 
USA) at an excitation wavelength of 488 and a 585±40-nm emission filter. 
2.12. Total glutathione measurement 
JWF2 cells were plated in 100 mm plates and cultured for 48 h. Media containing the 
appropriate treatments were added to the cells for the indicated time. Cells were washed with 
PBS and kept at -80 0C until the time of performing the assay. Cells were lysed in TEE buffer 
containing: 10 mM Tris base, 1 mM EDTA and 1 mM EGTA, with 0.5% Tween-20 and 1% 
triton X-100.  Total glutathione measurements were performed using Tietze method (Tietze, 
1969) with some modifications. Cell lysate was subjected to centrifugation at 10,000 rpm for 10 
minutes at 40C. The assay was performed in a 96 well plate by adding 25 µl of sample or 
oxidized glutathione standard (GSSG) (5µM, 2.5 µM, 1.75 µM, 0.875 µM and 0.437 µM) 
followed by 50 µl of chromagen (freshly prepared 1:1 solution of 1mM 2,2'-Dithiobis(5-
nitropyridine) (DTNP) and Glutathione reductase). DTNP (Sigma-Aldrich, St. Louis, MO) was 
prepared in 100mM Tris base buffer, pH 8.35) and Baker’s yeast Glutathione reductase (Sigma-
Aldrich, St. Louis, MO) was diluted 100 times in TEE buffer containing: 10 mM Tris base, 1 
mM EDTA and 1 mM EGTA, with 0.5% Tween-20. The mixture was incubated at room 
temperature for 15 minutes and then 25µl 10 mM NADPH (Sigma-Aldrich, St. Louis, MO) was 
added. The NADPH solution was prepared in 100mM Tris base, pH 8.35, aliquots were stored at 
-80 0C. Immediately after the addition of NADPH, the absorbance was measured kinetically 
(every 1 minute for 5 minutes) at 405 using the BioTek, Synergy HT plate reader.  
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2.13. Cyclic AMP measurement: 
JWF2 cells were plated in 96-well plates and cultured for 48 h. Cell were pretreated with 
appropriate concentration of cannabinoid receptor antagonists for 1 hour and then treated with 
AEA for 15 minutes. CAMP was measured using cAMP-Glo Max Assay kit (Promega, Madison, 
WI) according to manufacturer’s protocol. Luminescence was determined with a luminometer 
and used as a measure of cAMP produced. For each sample: the change in relative luminescence 
units (ΔRLU) = RLU (untreated sample) – RLU (treated sample) was calculated. Using this 
ΔRLU value and the linear equation generated from the standard curve, the cAMP concentration 
was calculated. 
2.14. Statistical analysis 
 All data are representative of three independent experiments. Data are presented as mean 
± Standard error of mean (SEM). Student’s T-test and Analysis Of Variance (ANOVA) 
followed by Tukey’s post-hoc analysis were carried out using GraphPad Prism and Microsoft 
Excel.
 
 
 
 
CHAPTER THREE: ARACHIDONOYL-ETHANOLAMIDE ACTIVATES 
ENDOPLASMIC RETICULUM STRESS-APOPTOSIS IN TUMORIGENIC 
KERATINOCYTES: ROLE OF CYCLOOXYGENASE-2 AND NOVEL J-SERIES 
PROSTAMIDES 
3.1. ABSTRACT 
Non-melanoma skin cancer and other epithelial tumors overexpress cyclooxygenase-2 
(COX-2), differentiating them from normal cells. COX-2 metabolizes arachidonic acid to 
prostaglandins including the J-series prostaglandins, which induce apoptosis by mechanisms 
including endoplasmic reticulum (ER) stress. Arachidonoyl-ethanolamide (AEA) is a 
cannabinoid that causes apoptosis in diverse tumor types. Previous studies from our group 
demonstrated that AEA was metabolized by COX-2 to J-series prostaglandins. Thus, the current 
study examines the role of COX-2, J-series prostaglandins, and ER stress in AEA-induced 
apoptosis. In tumorigenic keratinocytes that overexpress COX-2, AEA activated the PKR-like 
ER kinase (PERK), inositol requiring kinase-1 (IRE1), and activating transcription factor-6 
(ATF6) ER stress pathways and the ER stress apoptosis-associated proteins, C/EBP homologous 
protein-10 (CHOP10), caspase-12, and caspase-3. Using an ER stress inhibitor, it was 
determined that ER stress was required for AEA-induced apoptosis.  To evaluate the role of 
COX-2 in ER stress-apoptosis, HaCaT keratinocytes with low endogenous COX-2 expression 
were transfected with COX-2 cDNA or an empty vector and AEA-induced ER stress-apoptosis 
occurred only in the presence of COX-2. Moreover, LC-MS analysis showed that the novel 
prostaglandins, 15-deoxyΔ12,14PGJ2-EA and Δ12PGJ2/PGJ2-EA, were synthesized from AEA. 
These findings suggest that AEA will be selectively toxic in tumor cells that overexpress COX-2 
due to the metabolism of AEA by COX-2 to J-series prostaglandin-ethanolamides (prostamides). 
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Hence, AEA may be an ideal topical agent for the elimination of malignancies that overexpress 
COX-2.  
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3.2. INTRODUCTION 
 Non-melanoma skin cancer (NMSC) is the most common cancer in the United States. In 
2004, NMSCs were associated with estimated direct costs of $1.4 billion and indirect costs of 
$76.8 million. These costs are expected to rise dramatically because NMSC incidence is 
increasing due to excessive sun and artificial UV-light exposure. Therefore, novel treatments and 
improved prevention strategies are needed to address this issue. 
 A number of intriguing studies show that chemotherapeutic benefits may result from 
targeting the endoplasmic reticulum (ER) stress signaling pathway (reviewed in (Healy et al., 
2009)).  ER stress is caused by elevated protein folding loads, intracellular calcium imbalance 
and other cellular stresses which cause unfolded or misfolded protein accumulation (Boelens et 
al., 2007). In response to this, an intracellular signal transduction pathway, the unfolded protein 
response (UPR), alleviates ER stress to promote cell survival, or initiates cell death if the ER 
stress machinery is critically overloaded.  In tumor cells, moderate levels of ER stress are present 
due to increased proliferation rates, excessive protein processing, and limited energy (Luo et al., 
2009;Hsiao et al., 2009). Therefore, a therapeutic approach is to expose the tumor cells to ER 
stress inducers to overload the ER machinery thereby inducing cell death (Healy et al., 
2009;Verfaillie et al., 2010). In contrast, ER stress-mediated cell death is difficult to achieve in 
normal cells which typically contain low endogenous levels of ER stress (Healy et al., 2009).  
 The survival and cytotoxic ER stress pathways are regulated by three ER-resident stress 
sensors: double-stranded RNA-activated protein kinase (PKR)-like endoplasmic reticulum kinase 
(PERK), activating transcription factor-6 (ATF6), and inositol requiring kinase-1 (IRE1).  PERK 
is activated by autophosphorylation and phospho-PERK (P-PERK) phosphorylates the alpha 
subunit of eukaryotic initiation factor 2α (eIF2α) to attenuate global mRNA translation and 
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decrease the ER protein folding load (Marciniak and Ron, 2006;Shore et al., 2011). Activated 
ATF6 (90 kDa) translocates to the Golgi compartment where it is cleaved to a 50-kDa fragment 
that accumulates in the nucleus to increase the expression of genes encoding protein chaperones 
which alleviate ER stress (Shen and Prywes, 2005;Zhang and Kaufman, 2008). Also, IRE1 
becomes phosphorylated and functions as an endoribonuclease that removes a small intron from 
X-box binding protein1 (XBP1) mRNA.  XBP1 encodes a transcription factor that increases the 
expression of chaperones and enzymes involved in protein degradation thereby resolving ER 
stress (Zhang and Kaufman, 2008;Chakrabarti et al., 2011). Alternatively, in the presence of 
prolonged or overwhelming ER stress, these activated signaling pathways induce apoptosis by 
causing maximal induction of C/EPB homologous protein10 (CHOP10) transcription primarily 
via the ER stress responsive element (ERSE) and the amino acid responsive element (AARE) in 
the CHOP10 promoter (Oyadomari and Mori, 2004).  In addition, ER stress mediated apoptosis 
is triggered by ER resident caspase-12 (mouse) or caspase-4 (human), which do not activate 
apoptosis in the absence of ER stress (Nakagawa et al., 2000;Szegezdi et al., 2003).  Various 
agents with antineoplastic activity overload these ER stress pathways and initiate cell death, 
including proteasome inhibitors (Maria et al., 2013), NSAIDS (Du et al., 2011) and cannabinoids 
(Carracedo et al., 2006;Mecha et al., 2012). 
 Cannabinoids are bioactive signaling lipids that bind to cannabinoid receptors (CBR) to 
modulate processes such as pain and inflammation. Cannabinoids also regulate tumor survival by 
increasing cell death, inducing growth arrest, and inhibiting angiogenesis and metastasis 
(Grimaldi et al., 2006;Ramer and Hinz, 2008;Miyato et al., 2009;Patsos et al., 2010). 
Arachidonoyl-ethanolamide (AEA) is an endogenously synthesized cannabinoid that causes 
tumor cell death via receptor-dependent or -independent mechanisms (Alpini and DeMorrow, 
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2009;Brown et al., 2010;Van Dross et al., 2012).  Several cellular proteins regulate receptor-
independent AEA death including cyclooxygenase-2 (COX-2) (Van Dross, 2009;Kuc et al., 
2012).  
 COX-2 is an enzyme that is overexpressed in NMSCs and their precursor lesions and also 
promotes carcinogenesis (Buckman et al., 1998).  Clinical and animal tumor studies revealed that 
COX-2 inhibition decreases tumor development (Wilgus et al., 2003;Elmets et al., 2010). COX-2 
is the rate-limiting enzyme in prostaglandin (PG) synthesis from arachidonic acid (AA).  COX-2 
oxygenates AA to PGH2 which is then metabolized to PGE2, PGF2α, and PGD2, by prostaglandin 
synthase-E, -F, and -D, respectively. Subsequently, PGD2 is dehydrated to J-series 
prostaglandins.   J-series prostaglandins are well-known inducers of cell death (Clay et al., 
1999;Wang and Mak, 2011) and these cytotoxic lipids can cause apoptosis via ER stress 
(Takahashi et al., 1998;Chambers et al., 2007).  Interestingly, COX-2 metabolizes the 
cannabinoid AEA to ethanolamide (EA)-conjugated PGH2 which is then converted to PGE2-EA, 
PGF2α-EA, and PGD2-EA by prostaglandin synthases (Yu et al., 1997;Kozak et al., 2002b).  We 
previously determined that AEA was metabolized by COX-2 to J-series prostaglandins (25). 
However, it has not been determined if AEA-mediated apoptosis is caused by COX-2-
depdendent metabolism of AEA to J-series prostaglandins or by the induction of ER stress.  
Furthermore, the chemical identity of the J-series prostaglandins that are derived from AEA is 
also unknown. Hence, the current study examined the role of COX-2, J-series prostaglandins and 
ER stress in AEA-mediated apoptosis.  The results showed that AEA activated ER stress and 
apoptosis in a COX-2-dependent manner.  Moreover, we identified J-series prostaglandin-
ethanolamides (prostamides) as a novel subclass of prostaglandins that likely play a role in AEA-
mediated apoptosis.   Since COX-2 is overexpressed in tumor but not normal keratinocytes, our 
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findings suggest that AEA will be selectively converted to cytotoxic J-series prostamides in 
tumor cells thereby causing minimal toxicity in non-tumor cells.  
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3.3. RESULTS 
3.3.1. AEA was selectively toxic to tumorigenic keratinocytes  
To confirm our previous finding that AEA induces cell death selectively in NMSC cells 
which overexpress COX-2, tumorigenic (JWF2) and non-tumorigenic (HaCaT) keratinocytes 
were treated with different concentrations of AEA or vehicle for 24 hours and cell viability was 
measured using MTS assays. A significant reduction in cell viability was observed in JWF2 cells 
but not in HaCaT cells treated with 20 µM AEA. HaCaT cell viability was 35.7-fold higher than 
that of JWF2 cells in the presence of 20 µM AEA (Figure 3.1A). To assess whether the 
differential cytotoxicity of AEA in JWF2 and HaCaT cells might be associated with COX-2 or 
FAAH, the expression of these enzymes was examined. AEA is catabolized by FAAH to AA 
plus ethanolamine. Our previous data suggested that FAAH inhibition prevented AEA 
degradation thereby increasing the quantity of AEA that is available for metabolism by COX-2 
to J-series PGs (Kuc et al., 2012). FAAH expression levels were low in both tumorigenic (JWF2) 
and non-tumoregenic (HaCaT) keratinocytes (Figure 3.1B). On the other hand, COX-2 was 
overexpressed in JWF2 but not HaCaT cells. This suggests that JWF2 cells were more 
susceptible to cell death due to the metabolism of AEA by COX-2 to J-series PGs.    
3.3.2. AEA induced cell death in tumor cell lines with high COX-2 and low FAAH 
expression 
 The cytotoxicity of AEA was then examined in tumorigenic cell lines with variable levels 
of COX-2 and FAAH expression.  Two human colorectal cancer cell lines, HT29 and HCA7 
were treated with increasing concentrations of AEA for 24 hours and then cell viability was 
measured by conducting MTS assay. As shown in Figure 3.2A-B, 20 µM AEA induced cell 
death in HCA7 cells (Figure 3.2B), however, HT29 (Figure 3.2A) were resistant to AEA 
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cytotoxicity. To determine if AEA-induced cytotoxicity correlated with the magnitude of COX-2 
and FAAH expression, Western blot analysis was conducted. As shown in Figure 3.2C, COX-2 
expression was highest in HCA7 but moderate in HT29. However, the level of FAAH expression 
was higher in HT29 when compared to HCA7 cells. These data indicate that high COX-2 and 
low FAAH levels favor AEA cytotoxicity.   
3.3.3. AEA induced ER stress in NMSC cells 
 To evaluate whether AEA induces apoptosis via the ER stress pathway we first 
examined its ability to activate the ATF6, PERK, and IRE1 ER stress signaling pathways in 
tumorigenic keratinocytes.  JWF2 cells were exposed to 20 µM AEA or vehicle (ethanol) for 1, 
2, or 4 hours and ER stress sensor activation was measured.  Immunofluorescence analysis was 
conducted to investigate ATF6, which translocates from the cytoplasm to the nucleus when 
activated.  In AEA-treated cells, ATF6 was located in the nucleus whereas it was primarily 
observed in the cytoplasm of vehicle-treated cells (Figure 3.3A). To investigate the activation of 
PERK, the phosphorylation of PERK and its substrate, eIF2α were examined by conducting 
Western blot analysis.  PERK and eIF2α phosphorylation were increased as a result of cell 
treatment with AEA (Figure 3.3B, left panels).  A control experiment with the well-known ER 
stress inducer, thapsigargin, showed a similar but less intense increase in PERK and eIF2α 
phosphorylation (Figure 3.3B, right panels).  Activation of IRE1 was detected by examining its 
autophosphorylation and endoribonuclease activity.  IRE1 phosphorylation increased (2 hours) 
and then decreased (4 hours) in cells exposed to AEA (Figure 3.3C, top panel).  By employing 
RT-PCR analysis we also determined that unspliced (inactive) XBP1 mRNA was reduced in 
JWF2 cells treated with AEA indicative of P-IRE1 endoribonuclease activity (Figure 3.3C, 
bottom panel).  
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 Our previous data suggest that the cytotoxic effects of AEA in tumorigenic keratinocytes 
are dependent on the overexpression of COX-2 and the subsequent synthesis of J-series 
prostaglandins.  Therefore, J-series prostaglandin synthesis was measured to evaluate whether 
its production occurred in parallel with ER stress.  J-series prostaglandin synthesis was 
significantly increased (Figure 3.3D) in JWF2 keratinocytes, which overexpress COX-2 (Figure 
3.1B). J-series prostaglandin synthesis was elevated at 30 minutes (Figure 3.3D) and persisted 
up to 5 hours (data shown in Figure 3.9A) suggesting that these molecules play an important 
role in ER stress.  
3.3.4. ER stress was required for AEA-induced apoptosis 
 In the presence of overwhelming ER stress, activated ER stress sensors increase 
CHOP10 expression which ultimately leads to apoptosis.  To determine if AEA increases 
CHOP10 expression in tumorigenic keratinocytes, JWF2 cells were treated with AEA and 
Western blot analysis was conducted. AEA caused a substantial increase in CHOP10 expression 
(Figure 3.4A).  To determine if AEA also activated ER stress-associated apoptosis, cells were 
treated with AEA and the expression of caspase 12 and caspase 3 were measured.  AEA caused 
an increase in both pro-caspase 12 and its active, cleaved product (Figure 3.4B). In addition, 
caspase 3 cleavage was stimulated in the presence of AEA (Figure 3.4C and 3.4D).  
 Under conditions of ER stress PERK phosphorylates eIF2α and phosphorylated eIF2α 
(P- eIF2α) blocks global mRNA translation thus permitting resolution of the ER stress.  During 
insurmountable ER stress, CHOP10 activates PP1/GADD34 phosphatase, which 
dephosphorylates P-eIF2α allowing the resumption of mRNA translation. Consequently, the 
expression of proapoptotic proteins increases and apoptosis occurs (Yagi et al., 2003;Marciniak 
et al., 2004).  Salubrinal is a selective inhibitor of PP1/GADD34, which prevents P-eIF2α 
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dephosphorylation and subsequent mRNA translation thereby protecting cells from ER stress 
(Boyce et al., 2005).  To test whether AEA-induced apoptosis is mediated by the ER stress 
pathway, cells were pretreated with salubrinal.  AEA caused an initial increase in the 
phosphorylation of eIF2α at 2 hours followed by dephosphorylation at 6 hours.  Salubrinal 
prevented eIF2α dephosphorylation at the 6 hour time point as anticipated (Figure 3.5A). In 
addition, salubrinal reduced AEA-induced apoptosis (Figure 3.5B) and cell death (Figure 3.5C) 
confirming the involvement of ER stress in AEA-induced apoptosis.   
3.3.5. AEA was metabolized to J-series prostamides 
In this report and our previous study we measured J-series prostaglandin levels by ELISA 
and found that AEA increased J-series prostaglandin production (Kuc et al., 2012).  However 
ELISA does not provide information about the specific J-series prostaglandins that are 
synthesized.  To determine the identity of the J-series prostaglandins produced in the culture 
medium of AEA- or ethanol-treated JWF2 keratinocytes, LC-MS analysis was conducted by 
Allison Danell and Drisheka Thati, chemistry department, ECU.  PGJ2, Δ12PGJ2, and 15-
deoxy∆12,14PGJ2 are commercially available and were used as reference compounds to optimize 
the procedure for detecting J-series prostaglandins using mass spectrometry.  The reference 
compounds were added to fresh and spent media before and after extraction and yielded similar 
peak intensities for m/z 333 (PGJ2, ∆12PGJ2) and m/z 315 (15-deoxy∆12,14PGJ2) indicating that 
little to no sample was lost during the enrichment process (data not shown).  To identify the J-
series prostaglandins synthesized in AEA-treated cells LC-MS and LC-MS/MS was conducted.  
Novel J-series prostamides (EA, +43 amu) were detected at m/z 358 (15-deoxy∆12,14PGJ2-EA) 
and m/z 376 (PGJ2-EA, ∆12PGJ2-EA).  Figure 3.6A and 3.6B show LC-MS/MS spectra of m/z 
358 and 376, illustrating the use of MS/MS to confidently identify these m/z values.  The insets 
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in both showed that the ions of interest were detected in the LC-MS spectra of AEA-treated cells 
(red), but not in vehicle-treated cells (blue).  It is important to note that unconjugated J-series 
prostaglandins (PGJ2, ∆12PGJ2, and 15-deoxy∆12,14PGJ2) were not detected in JWF2 cells treated 
with AEA (data not shown).  This indicated that AA-derived, J-series prostaglandins were not 
major contributors to towards AEA-induced ER stress and apoptosis and also signified that the J-
series prostamides were not subject to cleavage by cellular enzymes. 
Because m/z 358 was observed in the LC-MS spectra of AEA-treated cells as well as in 
the LC-MS/MS spectra of m/z 376, a control experiment was conducted to approximate the 
extent of unintended dissociation of m/z 376.  The parent ion, m/z 376, was mass-selected and 
subjected to collision induced dissociation (CID) at the same collision energy used to transmit 
ions from the quadrupole to the time-of-flight in LC-MS (5 eV).  This low potential focuses the 
ion beam through the hexapole collision cell to obtain a conventional mass spectrum.  Only a 
low intensity m/z 358 peak was observed, indicating m/z 376 does not significantly dissociate to 
m/z 358 under the conditions used to obtain the LC-MS spectra (Figure 3.6C).  Thus, the 
majority of the signal at m/z 358 arises from the production of 15-deoxy∆12,14PGJ2-EA in the 
AEA-treated cells.   
3.3.6. AEA-induced ER stress was COX-2 dependent 
 Since J-series prostamides are products of the metabolism of AEA by COX-2 our goal 
was to determine if J-series prostamides mediate AEA-induced ER stress.  The rate-limiting 
enzyme in the production of all prostaglandins and prostamides is COX-2.  The role of COX-2 in 
AEA-induced ER stress and apoptosis however, could not be determined by genetic disruption or 
pharmacological inhibition of COX-2 because COX-2 inhibition causes tumor cell death (Sheng 
et al., 1997;Sheng et al., 1998).  The use of COX-2 inhibitors is further complicated by the fact 
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that these agents induce ER stress (Du et al., 2011).  Therefore, as an alternative approach the 
significance of COX-2 in AEA-induced apoptosis was determined by overexpressing COX-2 in 
keratinocytes with low endogenous levels of COX-2.  In AEA-treated cells, a substantial 
increase in eIF2α phosphorylation was observed in COX-2 compared with empty vector 
transfected cells (Figure 3.7A, right panels and Figure 3.7B).  In cells treated with AEA, ATF6 
was located in the nucleus of COX-2 transfected cells whereas ATF6 was primarily observed in 
the cytoplasm of cells transfected with the empty vector (Figure 3.7C, right panels and Figure 
3.7D). It is interesting to note that in experiments where AEA-treated cells were transfected with 
COX-2, eIF2α phosphorylation and ATF6 activation were increased in COX-2 containing cells 
(Figure 3.7B and 3.7D, inset) as well as in the neighboring cells.  This result provides support for 
the idea that ER stress is caused by J-series prostaglandins, which are known to be secreted from 
cells and act locally in a paracrine and autocrine manner. 
3.3.7. ER stress-mediated apoptosis in AEA-treated cells required COX-2 
 High magnitude CHOP expression is necessary for the initiation of apoptosis (Okada et 
al., 2002;Su and Kilberg, 2008). Since CHOP10 expression is regulated by responsive elements 
including the ERSE, we investigated whether ERSE promoter activity required COX-2.  AEA 
significantly increased ERSE promoter activity in HaCaTs with enforced COX-2 expression 
compared to empty vector-transfected cells (Figure 3.8A).  Consistent with these results, AEA 
increased CHOP10 protein expression in COX-2-transfected relative to empty vector-transfected 
cells (Figure 3.8B, 3.8C).  Next, the requirement for COX-2 in AEA-induced apoptosis was 
examined. Apoptosis was significantly induced by AEA in cells transfected with COX-2 (Figure 
3.8D and 3.8E). Taken together, these data show that in AEA-treated cells, COX-2 is required 
for ER stress-induced apoptosis.  
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3.3.8. J-series prostamide synthesis occurred in parallel with ER stress-apoptosis  
 COX-2 metabolizes AA to PGH2, which is converted by PGDS to PGD2; PGD2 is then 
dehydrated to J-series prostaglandins. To confirm that this synthetic pathway is preserved for 
AEA-derived J-series prostamides, JWF2 keratinocytes were exposed to the selective COX-2 
inhibitor, NS-398, prior to treatment with AEA and J-series prostamides were detected using 
LC-MS. The inhibition of COX-2 reduced J-series prostamides to low levels that were 
comparable to vehicle-treated cells (Figure 3.9A). To evaluate whether the blockade of J-series 
prostaglandin synthesis could prevent ER stress-mediated apoptosis, a PGDS inhibitor was 
utilized. Two distinct types of PGDS have been identified: lipocalin-PGDS (L-PGDS) and 
hematopoietic-PGDS (H-PGDS).  Both H-PGDS and L-PGDS were expressed in untreated 
JWF2 cells (Figure 3.9B). Next, JWF2 cells were exposed to SeCl4, an H-PGDS and L-PGDS 
inhibitor (Qu et al., 2006) followed by cell exposure to AEA. As anticipated, AEA significantly 
increased the production of D- and J-series prostaglandins (Figure 3.9C-D). Pretreatment of 
cells with SeCl4, caused a significant reduction in AEA-mediated D- and J-series prostaglandin 
synthesis. In addition, SeCl4 abrogated AEA-induced CHOP10 expression and caspase 3 
cleavage (Figure 3.9E) indicating the necessity of PGDS metabolic products for ER stress-
mediated apoptosis.  
3.3.9. PGD2-ethanolamide metabolism to J-series prostamides resulted in ER 
stress-mediated apoptosis  
 Synthetic J-series prostamides or selective inhibitors of J-series prostaglandin synthesis 
were not commercially available, therefore we could not directly determine if J-series 
prostamides mediated the cytotoxic effects of AEA.  Therefore, cells were exposed to the J-
series prostamide precursor PGD2-EA and ER stress, apoptosis, and J-series prostaglandin 
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synthesis were measured.  Figure 3.10A showed that 20 µM PGD2-EA increased the 
expression of CHOP10 and induced caspase-3 cleavage. LC-MS analysis of the culture 
medium from these experiments demonstrated that exogenously applied PGD2-EA was 
metabolized to 15-deoxy∆12,14PGJ2-EA (m/z 358) and that unconjugated 15-deoxy∆12,14PGJ2 
was not detected (Figure 3.10B).  The identity of m/z 358 was confirmed by conducting 
MS/MS (Figure 3.10C). These results verify that D-series prostamide was metabolized to J-
series prostamides that recapitulate the effects of AEA on ER stress-mediated apoptosis. 
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3.4. FIGURES 
Figure 3.1: AEA was preferentially toxic to tumorigenic keratinocytes that overexpress 
COX-2  
(A) Tumorigenic JWF2 and non-tumorigenic HaCaT keratinocytes were treated with different 
concentrations of AEA for 24 hours and cell viability was measured by conducting MTS assay. 
Fold difference in the viability of JWF2 and HaCaT cells treated with 20 µM AEA was 
calculated. (B) Western blot analysis was conducted to compare FAAH and COX-2 expression 
in JWF2 and HaCaT keratinocytes. COX-2 levels were normalized to the corresponding 
GAPDH value producing an optical density of 0.0024 and 0.810 in HaCaT and JWF2 cells, 
respectively. 
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Figure 3.2: AEA induced cell death in tumor cell lines with high COX-2 and low FAAH 
expression 
(A,B) Human colorectal carcinoma (HT29, A, and HCA7, B) were exposed to different 
concentration of AEA for 24 hours and cell viability was measured using MTS assay. (C) 
Western blot analysis was conducted to compare FAAH and COX-2 expression in HCA7and 
HT29 cells. FAAH levels were normalized to the corresponding GAPDH value producing an 
optical density of 2.14 and 0.97 in HT29 and HCA7 cells, respectively. COX-2 expression 
produced an optical density of 0.27 and 1.2 in HT29 and HCA7cells, respectively after 
normalization to the corresponding GAPDH value. 
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Figure 3.3: AEA caused ER stress in non-melanoma skin cancer cells 
(A) JWF2 cells were treated with 20 ∆M AEA or vehicle [ETOH as a solvent control; ≤ 0.1% 
(v/v) final concentration] for 2 hours.  ATF6 (green fluorescence) or the nuclear membrane 
protein, lamin B, (blue fluorescence) were detected by confocal microscopy (left panels).  
Histogram (right panels) represents the nuclear fraction (nuclear ATF6/ total ATF6) quantified 
from confocal images.  Data were analyzed using a t-test and are represented as mean ±SEM (*, 
P<0.05). (B) JWF2 cells were treated with 20 μM AEA or vehicle for 1 hour and 2 hours. Cells 
were also treated with thapsigargin (TG) for 2 hours as positive control for ER stress induction. 
The levels of phospho-PERK (P-PERK), total PERK (t-PERK), phospho-eIF2α (P-eIF2α), total 
eIF2α (t-eIF2α), and GAPDH (loading control) were examined by Western blot analysis.  Band 
intensities were quantified using ImageJ software.  Fold induction in protein expression was 
determined by comparing the band intensities of samples to vehicle-treated cells after 
normalizing GAPDH levels. (C, Top panels)  JWF2 cells were treated with 20 µM AEA for 2 
hours and 4 hours. Immunoblots show phospho-IRE1 (P-IRE1), total IRE1 (t-IRE1), and 
GAPDH. (C; Bottom panel) JWF2 cells were treated with AEA for 4 hours, mRNA isolated, and 
RT-PCR analysis was conducted. Negative control (NC) lane is RT-PCR reaction conducted in 
absence of mRNA. The marker used (M) is a low DNA Mass Ladder (Invitrogen). Unspliced 
(US) and spliced (S) XBP1 are shown. GAPDH mRNA levels were examined as a loading 
control. (D) JWF2 cells were treated with 20 µM AEA or vehicle for different periods of time 
and J-series prostaglandins measured by ELISA. Data were analyzed using a t-test and are 
represented as mean ±SEM (*, P<0.05).  
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Figure 3.4: AEA activated ER stress-apoptotic signaling in non-melanoma skin cancer cells  
(A-D) JWF2 cells were treated with 20 µM AEA or vehicle for 4 and 6 hours.  Western blot 
analysis was conducted to detect (A) CHOP10, (B) procaspase 12 and cleaved caspase 12, (C) 
full-length caspase 3 and cleaved caspase 3. GAPDH expression was used as loading control. (D) 
Histogram represents cleaved caspase 3 levels in JWF2 cells treated with AEA for 4 and 6 hours 
(represented in Figure 2C).  The densitometric values of cleaved caspase 3 from three 
independent experiments were analyzed using t- tests and are displayed as mean ±SEM (* 
indicates statistically significant difference between AEA-treated cells and vehicle-treated cells, 
P<0.05).  
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Figure 3.5 : ER stress was necessary for AEA-induced apoptosis in non-melanoma skin 
cancer cells  
JWF2 cells were pretreated for 1 hour with 50 µM salubrinal and then treated with 20 µM AEA 
or vehicle.  (A) Western blot analysis was conducted to examine P-eIF2α and t-eIF2α 
expression after 2 and 6 hours. (B) Cleaved caspase 3 was detected after 6 hours by conducting 
Western blot analysis.  The fold increase in protein expression compared with vehicle-treated 
cells was determined using ImageJ software and is indicated above each figure. (C) Cell 
viability was measured after 8 hours by conducting MTS experiments. Data were analyzed 
using one way ANOVA followed by Tukey’s multiple comparison test and are represented as 
mean ± SEM (* indicates statistically significant difference between the samples and vehicle-
treated cells and # indicates statistically significant difference between the samples and cells 
treated with AEA alone,  P<0.05). 
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Figure 3.6: AEA was metabolized to novel J-series prostamides 
(A, B) LC-MS/MS of peaks (A) m/z 358 and (B) m/z 376 was used to confirm identity of J-
series prostamides in AEA-treated JWF2 cells. J-series prostamide signal was only observed in 
AEA-treated (insets, red), but not EtOH-treated (insets, blue) cells. Note PGJ2-EA and ∆12PGJ2-
EA are isomers (m/z 376) which co-elute from the LC and cannot be distinguished based on m/z. 
(C) LC-MS/MS at 5eV collision energy produced a peak at m/z 358, with an intensity that was 
much lower than the 15-deoxy∆12,14PGJ2-EA metabolite peak observed in LC-MS spectra from 
JWF2 cells. 
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Figure 3.7 : AEA-induced ER stress was dependent on COX-2 
HaCaT cells were transfected with PcDNA6.1-h-COX-2 (red fluorescence) or the empty vector, 
pcDNA6.1, and treated with 20 μM AEA or vehicle for 2 hours. (A) P-eIF2α (green 
fluorescence) was detected by confocal microscopy. (B) Histogram shows quantification of the 
intensity of P-eIF2α fluorescence in all cells or only in cells that express COX-2 (inset). (C) 
ATF6 (green fluorescence) was detected by confocal microscopy. (D) Histogram shows 
quantification of the nuclear fraction of ATF6 in all cells or only in cells that express COX-2 
(inset). Data were analyzed using ANOVA followed by Tukey’s multiple comparison tests. Data 
are represented as mean +SEM (* represents statistically significant difference from vehicle-
treated empty vector transfected cells and # represents statistically significant difference from 
AEA-treated empty vector transfected cells, P<0.05). Data in inset were analyzed using a t-test 
and are represented as mean ±SEM (*, P<0.05).    
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Figure 3.8: AEA-induced CHOP10 expression and apoptosis required COX-2 
HaCaT cells were transfected with PcDNA-6.1-h-COX-2 or PcDNA6.1 (empty vector control) 
and treated with 20 μM AEA or vehicle. (A) HaCaT cells were co-transfected with the 
luciferase-tagged ERSE reporter plus Renilla luciferase and treated with 20 µM AEA or vehicle 
for 2 hours (left).  ERSE-luciferase plus Renilla luciferase-transfected HaCaT cells were treated 
with thapsigargin (TG) as positive control (right). (B-E) HaCaT cells were transfected with 
PcDNA-6.1-h-COX-2 or PcDNA6.1 and treated with 20 µM AEA or vehicle.  (B) CHOP10 
(green fluorescence) and COX-2 (red fluorescence) expression were detected after 7 hours by 
conducting confocal microscopic analysis. (C) Histogram shows quantification of the intensity of 
CHOP10 fluorescence. Data were analyzed using ANOVA followed by Tukey’s multiple 
comparison test. Data are represented as mean +SEM (* represents statistically significant 
difference from vehicle-treated empty vector transfected cells and # represents statistically 
significant difference from AEA-treated empty vector transfected cells, P<0.05). The inset shows 
CHOP10 intensity only in cells that express COX-2.  Data in inset were analyzed using a t-test 
and are represented as mean ±SEM (*, P<0.05).  (D) Activated caspase-3 (green fluorescence) 
and COX-2 (red fluorescence) were detected after 10 hours using confocal microscopy. (E) 
Histogram represents the number of COX-2 (red fluorescence) and activated Casp-3 (green 
fluorescence) expressing cells measured as a fraction of the total number of cells in the same 
field. Data were analyzed using ANOVA followed by Tukey’s multiple comparison test and are 
represented as mean ±SEM (* represents statistically significant difference from vehicle-treated 
empty vector transfected cells and # represents statistically significant difference from AEA-
treated empty vector transfected cells, P<0.05). 
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Figure 3.9: AEA-derived J-series prostaglandins were required for ER stress and apoptosis 
(A) JWF2 cells were treated with COX-2 inhibitor, NS-398, followed by AEA (20 µM) or 
vehicle for 5 hours.  PGJ2-EA/ Δ12PGJ2-EA (m/z 376) and 15-deoxy∆12,14PGJ2-EA (m/z 358) 
that accumulated in the media were detected by conducting mass spectrometry analysis.  (B) 
Hematopoietic and Lipocalin PGDS expression was examined in untreated JWF2 cells (duplicate 
samples) by conducting Western blot analysis. GAPDH expression was used as loading control. 
(C-D) JWF2 cells were pretreated with SeCL4 and then treated with 20 µM AEA or vehicle for 4 
hours. ELISA analysis was conducted to measure D-series prostaglandins (C) and J-series 
prostaglandins (D) as directed by the manufacturers. Data were analyzed using one way ANOVA 
followed by Tukey’s multiple comparison test and are represented as mean ±SEM (* indicates 
statistically significant difference between the samples and vehicle-treated cells and # indicates 
statistically significant difference between the samples and cells treated with AEA alone,   
P<0.05). (E) CHOP10 and cleaved caspase 3 levels were examined in cells pretreated with 100 
µM SeCl4 and treated with 20 µM AEA or vehicle by conducting Western blot analysis. The 
fold increase in protein expression compared with vehicle-treated cells is shown above the 
figure. 
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Figure 3.10:  PGD2-EA was metabolized to J-series prostamides that increased CHOP10 
and apoptosis  
JWF2 cells were treated with 5, 10 and 20 µM PGD2-EA or vehicle for 7, 16 and 20 hours. (A) 
The expression of CHOP10 and cleaved caspase 3 was examined by conducting Western blot 
analysis. Culture medium from experiments in (A) was collected after 7 hours, prostaglandins 
extracted and (B) LC-MS was conducted to detect 15-deoxy∆12,14PGJ2-EA (m/z 358). 15d-PGJ2 
(m/z 315,*) is not detected. (C) The identity of 15-deoxy∆12,14PGJ2-EA was confirmed with LC-
MS/MS. (D) Proposed pathway of AEA-induced apoptosis.  We propose that in tumor cells 
which overexpress COX-2, AEA is metabolized by COX-2 followed by PGDS to J-series 
prostamides. J-series prostamides then induce overwhelming ER stress which increases CHOP10 
expression and initiates the apoptotic cascade.  
 
 
62 
 
 
 
 
 
 
 
 
 
63 
 
3.5. DISCUSSION 
 Gaining an understanding of the molecular mechanisms underlying AEA-induced 
apoptosis in tumor cells is a topic of increasing interest.  In the present report, we determined 
that AEA was selectively toxic to COX-2 overexpressing cells. AEA also caused ER stress and 
that signaling through the ER stress pathway was necessary for AEA-induced apoptosis. In 
addition, AEA-stimulated ER stress and apoptosis only occurred in the presence of COX-2.  
Moreover, we demonstrated for the first time that AEA was metabolized by COX-2 to the novel 
J-series prostamides, PGJ2-EA, Δ12PGJ2-EA, and 15-deoxy∆12,14PGJ2-EA.  Furthermore, J-series 
prostamide synthesis was required for ER stress-associated apoptosis initiated by AEA.  Hence, 
the results of this study support our hypothesis that AEA is metabolized by COX-2 to J-series 
prostamides that activate apoptotic ER stress (Figure 3.10D).  
 Several groups have demonstrated that COX-2 activity is necessary for AEA-induced cell 
death.  For example, AEA and its analog, R(+)-methanandamide caused COX-2 dependent cell 
death in colorectal carcinoma and neuroglioma cells, respectively (Ramer et al., 2001;Patsos et 
al., 2010).  Furthermore, AEA-initiated apoptosis was partially mediated by COX-2 in 
embryonal carcinoma cells (47). In the current study, we demonstrated that COX-2 was 
necessary for apoptosis mediated by AEA (Figure 3.8).  A few of the above mentioned reports 
specifically identify COX-2 metabolic products of AEA as mediators of apoptosis.  However, 
since AEA is also metabolized by enzymes including 12-lipoxygenase (Edgemond et al., 1998) 
and P450 enzymes (Snider et al., 2009), it is possible that these endogenous enzymes play a role 
in AEA-induced ER stress and apoptosis.  The data presented here however, argue against the 
idea that AEA-mediated apoptosis is caused by lipoxygenases, P45Os, or other enzymes since 
we did not observe ER stress-associated apoptosis in AEA-treated cells that lacked COX-2 
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expression (Figure 3.7 and Figure 3.8, AEA-treated, empty vector transfected cells).  Thus, 
COX-2 is a prominent regulator of AEA-mediated apoptosis.  
 Since AEA-induced cell death is dependent on COX-2, it is reasonable to propose that 
COX-2 promotes apoptosis by converting AEA to J-series prostamides.  Our data showed that 
novel J-series prostamides were synthesized in AEA-treated cells that overexpress COX-2 
(Figure 3.6).  In addition, blockade of J-series prostamide synthesis using a PGDS inhibitor 
prevented AEA-induced ER stress and apoptosis (Figure 3.9).  Moreover, exogenous PGD2-EA 
was converted to J-series prostamides which mimicked the effects of AEA by inducing ER 
stress-apoptosis (Figure 3.10A-C).  Furthermore, an earlier report by our group demonstrated 
that only exogenous D- and J-series prostaglandins (but not E-and F-type prostaglandins) were 
capable of inducing cell death in tumorigenic keratinocytes.  Thus, it appears that AEA-induced 
ER stress-apoptosis is mediated by J-series prostamides.  Unfortunately, it was not possible to 
directly test whether J-series prostamides initiated ER stress-mediated apoptosis since these 
bioactive lipids or their specific inhibitors were not commercially available.  However, various 
groups have demonstrated that J-series prostaglandins that are derived from AA cause apoptosis 
by different cellular mechanisms.  It has been reported that 15-deoxyΔ12,14PGJ2 activated the 
apoptotic cascade via agonism of PPAR-gamma (Clay et al., 1999).  15-deoxyΔ12,14PGJ2 also 
induced apoptosis in HCT-116 cells by activating the ER stress pathway (Su et al., 2008).  
Hence, the proposal that J-series prostamides are ultimately responsible for AEA-induced ER 
stress and apoptosis is consistent with the data presented here and the known effects of 
arachidonic acid-derived J-series PGs.   
 Whether J-series prostaglandins induce tumor cell apoptosis in vivo is controversial.   A 
study by Clay et al. reported that AA-derived 15-deoxyΔ12,14PGJ2 activated the apoptotic cascade 
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in MDA-MB-231 breast cancer cells and prevented breast cancer cell tumorigenesis (Clay et al., 
1999).  In contrast, Millan et al. found that 15-deoxyΔ12,14PGJ2 increased DMBA/TPA-mediated 
skin tumor development when applied topically during tumor initiation (Millan et al., 2006).  
These opposing effects might be due to the drug dosage used in each study as J-series 
prostaglandins, like most pharmacological agents, produce biphasic effects (Levonen et al., 
2001). Thus, it is possible that J-series prostamides will promote tumor cell death similar to J-
series prostaglandins under optimal experimental conditions.  However, it is premature to assume 
that J-series prostamides will exhibit the same effects as its AA-derived counterpart.  A study by 
Matias et al., showed that AEA-derived prostamides (PGE2-EA, PGF2α-EA, and PGD2-EA) elicit 
cat iris contraction independent of EP-, FP- and DP-receptors unlike AA-derived prostaglandins 
(PGE2, PGF2α, and PGD2) (Matias et al., 2004).  Although cell surface receptors for J-series 
prostaglandins have not been identified, the report by Matias suggests that the effects of AEA-
derived J-series prostamides may be distinct from arachidonic acid-derived, J-series 
prostaglandins.  To gain a better understanding of its activity in vitro and in vivo, J-series 
prostamides have been synthesized and are being characterized by our group. 
 AEA-induced death is regulated by several cell signaling pathways.  The induction of cell 
death by AEA was reported to be dependent upon the stimulation of ceramide synthesis and 
Fas/FasL localization to lipid rafts in cholangiocarinoma cells (DeMorrow et al., 2007).  In 
addition, AEA-induced neuroblastoma apoptosis was prevented by TRPV1 channel inhibition 
through a calcium sensitive mechanism (Maccarrone et al., 2000).  Also, AEA cytotoxicity was 
found to be regulated by the activity of enzymes that promote endocannabinoid degradation 
(Bifulco et al., 2004;Siegmund et al., 2006;Kuc et al., 2012).  Our data suggest that ER stress is 
another signaling pathway that regulates AEA-induced apoptosis.  We found that AEA 
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stimulated the expression and activity of multiple ER stress proteins and also induced apoptosis 
(Figure 3.3 and 3.4).  In addition, AEA-induced cell death was partially reversed by interfering 
with ER stress signaling (Figure 3.5 A-C).  Consistent with these results, other groups have 
demonstrated that ER stress regulates cannabinoid-induced cell death.  For instance, in 
neuroblastoma cells AEA-mediated apoptosis was blocked by disabling the ER stress protein BiP 
(Pasquariello et al., 2009). Carracedo et al. showed that apoptosis caused by Δ9 
tetrahydrocannabinol (Δ9-THC) required CB2R and ceramide-induced ER stress in pancreatic 
tumor cells (Carracedo et al., 2006).  Also, J-series prostaglandins that are derived from AA 
initiate apoptosis via the ER stress pathway (Su et al., 2008).  Furthermore, it has been 
demonstrated that synthetic prostaglandins with structures similar to J-series prostaglandins 
accumulate in the ER and trigger activation of BiP (Takahashi et al., 1998).  Thus, the 
endocannabinoid, AEA, and its J-series prostamide metabolic products, likely initiate apoptosis 
by inducing ER stress.   
 The molecular events required for activation of the apoptotic ER stress pathway are 
unclear but a few important studies are beginning to shed light on this issue.  Lin et al 
demonstrated that the initiation of apoptotic ER stress required continuous PERK signaling 
accompanied by the activation and subsequent deactivation of IRE1 and ATF6 in human 
embryonic kidney cells (Lin et al., 2007). Moreover, this group demonstrated that increasing 
IRE1 expression under these conditions prevented cell death indicating that IRE1 inactivation 
was necessary for apoptosis. Another study determined that under low levels of ER stress the 
endonuclease activity of IRE1 promoted splicing of XBP1 and cell survival.  However, intense 
ER stress initiated global splicing of mRNAs present within the ER and triggered the apoptotic 
cascade in insulinoma cells (Han et al., 2009). In addition, Su et al determined that the magnitude 
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of proapoptotic CHOP10 expression was a critical determinant of apoptotic ER stress in HepG2 
cells as maximal but not moderate levels of CHOP10 caused ER stress-mediated apoptosis (Su 
and Kilberg, 2008). Our data show that some elements of these pathways are preserved in 
tumorigenic keratinocytes treated with AEA.   Specifically, we found IRE1 was activated and 
then deactivated in JWF2 keratinocytes (Figure 3.3C) similar to the findings of Lin et al.  Also, 
AEA caused high level CHOP10 expression and apoptosis in HaCaT cells with ectopic COX-2 
expression however, in the absence of COX-2, AEA-induced CHOP10 levels were low and 
apoptosis did not occur (Figure 3.8).  Thus, it is tempting to speculate that IRE1 deactivation and 
elevated CHOP10 levels were essential triggers of ER-stress apoptosis in keratinocytes treated 
with AEA.  Given the diversity of pathways that have been shown to activate apoptosis, 
cytotoxic ER stress likely occurs in a cell type- and context-specific manner. Future studies with 
AEA will seek to identify the ER stress pathway proteins that are needed to initiate apoptosis in 
tumorigenic epithelial cells that overexpress COX-2. 
 The data presented in this dissertation show that AEA is cytotoxic to cells that 
overexpress COX-2.  We have identified novel J-series prostamides as likely regulators of 
apoptosis, which our data implies was mediated by ER stress.  The requirement for COX-2 in 
AEA-induced ER stress-apoptosis suggests that rather than inhibiting COX-2 as a therapeutic 
strategy, we can take advantage of COX-2 overexpression in tumor cells to metabolize AEA to 
these cytotoxic J-series prostamides.  Since the endogenous levels of COX-2 are low in non-
tumor keratinocytes, AEA may produce selective toxicity in tumor cells and provide an effective 
approach for topical treatment of NMSC or other cancers that overexpress COX-2.  
 
 
 
 
CHAPTER FOUR: ANANDAMIDE-INDUCED APOPTOSIS IN NON-MELANOMA 
SKIN CANCER IS MEDIATED BY OXIDATIVE STRESS IN A RECEPTOR- 
INDEPENDENT MANNER 
4.1. ABSTRACT 
Endocannabinoids are neuromodulatory lipids that regulate central and peripheral 
physiological functions. Endocannabinoids have emerged as effective antitumor drugs due to 
their ability to induce growth arrest and apoptosis in a series of cancer studies. In several reports, 
the antiproliferative activity of these biological lipids was mediated by the G-protein coupled 
receptors, CB1 and CB2. However, recent studies have demonstrated that receptor-independent 
effects may also account for their activity. Our previous studies reported that the antiproliferative 
activity of anandamide (aka arachidonyl ethanolamide, AEA) was regulated by COX-2 via the 
ER stress pathway.  In addition, we determined that AEA induced oxidative stress. Moreover, 
AEA-induced cell death occurred by a cannabinoid receptor-independent mechanism. However, 
it was unclear if oxidative stress was required for apoptosis and if oxidative and ER stress 
occurred in a receptor-dependent or -independent manner. Therefore, the current study examines 
the role of oxidative stress in the induction of ER stress-mediated apoptosis and investigates 
whether this effect is caused by CB1 and/or CB2 receptors. In the non-melanoma skin cancer 
(NMSC) cell line, JWF2, AEA reduced the total intracellular level of glutathione and induced 
oxidative stress. To evaluate the importance of oxidative stress in AEA-induced cell death, N-
acetyl cysteine (NAC) and Trolox antioxidants were used. The two antioxidants ameliorated the 
antiproliferative effect of AEA. Furthermore, Trolox inhibited AEA-induced CHOP10 
expression and caspase 3 cleavage, indicating that oxidative stress is required for AEA-induced 
ER stress-apoptosis. On the other hand, selective blockade of the CB1 and CB2 receptors did not 
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inhibit AEA-induced oxidative stress, ER stress or apoptosis. These findings suggest that AEA-
induced ER stress-apoptosis in NMSCs is mediated by oxidative stress through a receptor-
independent mechanism. Hence, receptor-independent AEA signaling pathway may be targeted 
to eliminate NMSC cells.  
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4.2. INTRODUCTION 
Cannabinoids are a diverse class of compounds that regulate physiologic and pathologic 
processes including the appetite, mood, learning/memory, pain sensation and inflammation.  
Cannabinoids have been utilized clinically and in animal studies to prevent the adverse effects 
associated with cancer chemotherapy. The cannabinoids dronabilone and nabilone are clinically 
approved to prevent chemotherapy-induced nausea and vomiting (Tramer et al., 2001;Alexander 
et al., 2009). Also, the cannabinoid N-arachidonoyl ethanolamide [(AEA); also known as 
anandamide], reduced pain and neurotoxicity caused by the cancer chemotherapeutic agent, 
cisplatin in an animal pain model (Khasabova et al., 2012). Many reports indicate that 
cannabinoids are also potent antineoplastic agents. It has been reported that these agents promote 
tumor cell death by initiating growth arrest (Fowler et al., 2003;Laezza et al., 2006;Frampton et 
al., 2010;Linsalata et al., 2010), inducing apoptosis and necrosis (Miyato et al., 2009;Wu et al., 
2010;Patsos et al., 2010), and inhibiting angiogenesis and metastasis (Grimaldi et al., 
2006;Pisanti et al., 2007;Laezza et al., 2008).   
The biological effects of the endogenously synthesized cannabinoid (endocannabinoid), 
AEA, are primarily mediated by its interaction with cannabinoid receptors. The two classical 
cannabinoid receptor subtypes are cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 
(CB2). Both cannabinoid receptors are G-protein coupled and transduce signals through the Gi/o 
protein (Das et al., 1995).  Numerous studies demonstrate that cannabinoid receptor activation is 
required for the antineoplastic activity of AEA in some but not all tumor cells (Cianchi et al., 
2008).  AEA-mediated inhibition of cell proliferation was blocked by a selective CB1 receptor 
antagonist in breast and prostate cancer cell lines (De et al., 1998;Melck et al., 1999;Melck et al., 
2000;Nithipatikom et al., 2011). In contrast, the induction of apoptosis by AEA was not 
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prevented by CB1 and CB2 receptor antagonists in various colon cancer cell lines (Gustafsson et 
al., 2009;Patsos et al., 2010) indicating that cannabinoid receptor modulation of tumor growth 
may be cell type or context dependent.  
The cannabinoid receptor-independent antineoplastic activity of AEA is regulated by 
diverse molecular pathways. In cholangiosarcoma cells, AEA-induced cell death was mediated 
by increased ceramide production and Fas/FasL localization to lipid rafts and the use of CB1 or 
CB2 receptor antagonists did not inhibit the antiproliferative effect of AEA. (DeMorrow et al., 
2007).  In addition, AEA-induced apoptotic cell death in colon and skin cancer cell lines required 
COX-2 (Patsos et al., 2010;Soliman et al., 2014).  COX-2 is an enzyme that promotes tumor 
growth and is overexpressed in different malignancies such as colon, breast, lung, and skin 
cancer.  COX-2 metabolizes arachidonic acid to prostaglandins including PGE2 or 15deoxy, 
Δ12,14PGJ2 (15d-PGJ2) which initiates tumor cell growth or apoptosis, respectively.  The anti-
tumor effects of J series prostaglandins were mediated by oxidative stress in several reports 
(Takahashi et al., 1998;Saito et al., 2003;Weber et al., 2004;Chambers et al., 2007;Wang and 
Mak, 2011).  Oxidative stress is caused by an imbalance in the production of cellular oxidants 
and their neutralization by enzymatic and non-enzymatic antioxidants in a cell (Mates et al., 
2012). The most important endogenous non-enzymatic antioxidant is glutathione (GSH), a thiol-
containing compound that maintains the intracellular redox balance. The reduction of GSH levels 
shifts the redox balance towards cellular oxidants and causes oxidative stress (Kondo et al., 
2001).  The overabundance of oxidative molecules in the cell causes damage to DNA, proteins 
and lipids and often leads to cell death (Kaur et al., 2014).  Oxidative stress is also an important 
initiator of endoplasmic reticulum (ER) stress (Malhotra and Kaufman, 2007;Verfaillie et al., 
2012;Niforou et al., 2014). ER stress occurs when stressors such as oxidative stress, increased 
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protein folding loads and calcium imbalance interfere with the cells ability to properly fold 
proteins leading to an accumulation of unfolded proteins and initiation of the unfolded protein 
response (UPR).  Low levels of ER stress are resolved by activation of the ER sensors PERK, 
ATF6, and IRE1.  Excessive or prolonged ER stress then triggers the expression of cytotoxic ER 
stress protein, CHOP-10 and ultimately initiates apoptosis (Lin et al., 2008;Chakrabarti et al., 
2011).  Previous studies from our group showed that the endocannabinoid, AEA selectively 
induces death in tumor cells in a COX-2-dependent and cannabinoid receptor-independent 
manner.  In addition, we determined that ER stress and oxidative stress were required for AEA-
induced apoptosis (Kuc et al., 2012;Soliman et al., 2014).  However, the role of oxidative stress 
and the cannabinoid receptors in AEA-induced ER stress-apoptosis was unclear.  The present 
study was undertaken to determine whether oxidative stress was essential for AEA-induced ER 
stress and apoptosis.   Moreover, we examined whether AEA-induced apoptosis, oxidative stress, 
or ER stress are mediated by CB receptors.  The results of our work suggest that in tumor cells 
which overexpress COX-2, AEA generates oxidative stress which activates the cytotoxic ER 
stress pathway in a cannabinoid receptor-independent manner. 
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4.3. RESULTS  
4.3.1. AEA induced oxidative stress, ER stress and apoptosis in NMSCs  
To confirm our previous finding that AEA induces cell death in NMSC cells, JWF2 
keratinocytes were treated with different concentrations of AEA or vehicle for 8 hours and cell 
viability was measured using MTS assays. A significant reduction in cell viability was observed 
in cells treated with 10 - 40 µM AEA (Figure 4.1A). To validate that AEA-induced cell death 
occurred via ER stress-mediated apoptosis, cells were treated with 20 µM AEA and Western blot 
analysis was conducted to detect the expression of CHOP10, a marker for cytotoxic ER stress 
and cleaved caspase 3, an indicator of apoptosis (Figure 4.1B). CHOP10 expression and caspase 
3 cleavage were stimulated by AEA in JWF2 cells confirming that cell death is mediated by ER 
stress-apoptosis.  
We previously showed that AEA is metabolized by COX-2 to 15d-PGJ2-EA and that this 
novel prostaglandin is likely responsible for the cytotoxic activity of AEA.  Other groups have 
shown that COX-2 also metabolizes arachidonic acid to 15d-PGJ2.  Several studies indicate that 
15d-PGJ2 causes cell death by inducing oxidative stress (Kondo et al., 2001;Uchida and Shibata, 
2008).  However, since 15d-PGJ2-EA was not commercially available and 15d-PGJ2-EA and 
15d-PGJ2 are structurally similar, 15d-PGJ2 was used to investigate whether J-series 
prostaglandins induce oxidative stress in tumorigenic keratinocytes. JWF2 cells were treated 
with AEA or 15d-PGJ2 in the presence of the oxidative stress indicator, CM-H2DCFDA and flow 
cytometric analysis was conducted. AEA caused a concentration-dependent increase in DCF 
oxidation (Figure 4.1C).  15d-PGJ2 also significantly increased DCF fluorescence relative to 
vehicle-treated cells.  In addition, AEA and 15d-PGJ2 produced greater DCF oxidation in JWF2 
cells than H2O2 which was used as a positive control.  Collectively, these data indicate that AEA 
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is a potent inducer of oxidative stress and that the J-series metabolite of AEA could be 
responsible for this activity.   
  It has been demonstrated previously that a mechanism by which the arachidonic acid 
metabolite, 15d-PGJ2, causes oxidative stress is by reducing total intracellular glutathione (GSH) 
levels (Levonen et al., 2001;Wang and Mak, 2011). To determine if AEA also decreases GSH, 
JWF2 cells were exposed to AEA, 15d-PGJ2 or vehicle and then glutathione levels were 
measured.  Figure 4.1D shows that the concentration of glutathione was significantly reduced by 
20 µM AEA and 5 µM 15d-PGJ2 suggesting that the cells capacity to rebound from this 
oxidative state may be compromised. Next, JWF2 cells were treated with AEA, the cells were 
divided, and flow cytometric analysis was conducted to detect oxidative stress (CM-H2DCFDA) 
or ER stress (phosphorylated eIF2α).  The mean fluorescence intensity of DCF (Figure 4.1E) and 
phospho-eIF2α (Figure 4.1F) were markedly increased indicating that both oxidative- and ER-
stress occur and play an important role in AEA-induced apoptosis.       
4.3.2. Oxidative stress was needed for the initiation of ER stress-apoptosis 
 To determine if oxidative stress was essential for AEA cytotoxicity, the intracellular 
oxidative environment was neutralized using the antioxidants, N-acetyl cysteine (NAC) and 
Trolox. NAC is a precursor of glutathione, which binds to and inactivates reactive molecules 
(Zafarullah et al., 2003).  JWF2 keratinocytes were preincubated with different concentrations of 
NAC, treated with AEA, and CM-H2DCFDA oxidation measured.  NAC prevented AEA-
induced oxidative stress in a concentration-dependent manner (Figure 4.2A).  To evaluate 
whether a reduction in intracellular glutathione levels may have contributed to AEA-induced 
oxidative stress, total glutathione was measured.  NAC restored the endogenous glutathione 
levels in AEA-treated cells (Figure 4.2B). A similar effect on AEA-induced oxidative stress was 
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observed when JWF2 cells were pretreated with Trolox (Figure 4.2C and 4.2D). Trolox is a 
water-soluble analog of vitamin E and exhibits antioxidant activity by scavenging free radicals 
(Mazor et al., 2006). Trolox (0.5 mM) completely inhibited AEA-induced oxidative stress 
although a significant restoration of endogenous glutathione levels was not seen. Furthermore, a 
reversal of AEA-induced cell death was seen in cells treated with NAC (Figure 4.2E) and partial 
reversal was seen with Trolox (Figure 4.2F). 
 The thiol group in NAC likely interacts directly with the double bond in the 
cyclopentanone ring of 15d-PGJ2 leading to inactivation of 15d-PGJ2.  Therefore, the inhibition 
of AEA-induced cell death and oxidative stress shown in Figure 4.2A and 4.2E may have been 
caused by sequestration of the AEA metabolite, 15d-PGJ2-EA, rather than by global modulation 
of the redox environment. As such, Trolox was utilized to determine the role of oxidative stress 
in AEA-induced ER stress and apoptosis. Trolox inhibited CHOP10 protein expression induced 
by AEA (Figure 4.3A).  In addition, the data show that apoptosis mediated by AEA was 
prevented with Trolox (Figure 4.3B). These findings indicate that the generation of oxidative 
stress was important for the initiation of ER stress-mediated apoptosis.   
4.3.3. The antiproliferative activity of AEA was not mediated by cannabinoid 
receptors  
The cytotoxic effects of AEA are regulated by cannabinoid receptor-dependent and -
independent pathways (Van Dross R. et al., 2013). CB1 and CB2 receptors are Gi-coupled 
receptors that inactivate adenylate cyclase thereby reducing cAMP levels in the presence of 
cannabinoid receptor agonists. JWF2 cells were pretreated with selective CB1R (AM251) and 
CB2R (AM630) antagonists to identify concentrations that prevented the agonist-mediated 
reduction in cAMP. In AEA-treated cells, the reduction in cAMP was inhibited by 0.001-0.1 µM 
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AM251 and AM630. In contrast, this trend was reversed by 1 µM of AM251 and AM630 
(Figure 4.4A).  Therefore, cells were treated with 0.1 µM of the receptor antagonists in our 
studies.  To determine whether AEA-induced apoptosis required cannabinoid receptor activation, 
JWF2 cells were pre-incubated with AM251or AM630 and then treated with AEA. Antagonism 
of the CB1 or CB2 receptor did not inhibit AEA-induced caspase 3 cleavage (Figure 4.4B & 
4.4C). The effect of the cannabinoid receptors on the antiproliferative activity of AEA was also 
examined. AEA-mediated cell death occurred despite the presence of the CB1 and CB2 receptor 
antagonists.  Hence, AEA-induced apoptosis and cell death occur through a receptor-independent 
mechanism.   
4.3.4. AEA-induced oxidative stress and ER stress were not mediated by the 
cannabinoid receptors   
 Oxidative- and ER-stress are necessary for the initiation of apoptosis by AEA (Figure 
3.5B and Figure 4.3B).  Therefore, we examined whether AEA-induced oxidative- and ER-stress 
were regulated by the cannabinoid receptors. As we observed previously, AEA increased 
oxidative stress in JWF2 cells.  Pretreatment of the cells with AM251 or AM630 did not block 
the production of oxidative stress caused by AEA (Figure 4.5A & 4.5B).  Similarly, the increase 
in CHOP10 expression mediated by AEA was not prevented by cannabinoid receptor 
inactivation (Figure 4.5C & 4.5D).  Collectively, these results imply that AEA-induced ER 
stress-mediated apoptosis is a process that does not require cannabinoid receptor activity. 
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4.4. FIGURES 
Figure 4.1: AEA induced oxidative stress and ER stress in NMSCs 
(A) Cell viability was measured by MTS assay in JWF2 cells treated with the indicated 
concentration of AEA for 8 hours. (B) JWF2 cells were treated with AEA (20 µM) or vehicle 
(ETOH) for 4 and 6 hours. CHOP10 expression and cleaved caspase3 (Cl- Casp3) were analyzed 
by Western blot analysis. GAPDH expression was measured as loading control. Band intensities 
were quantified using ImageJ software. Fold induction was determined by comparing the band 
intensities of samples to vehicle-treated cells after normalizing GAPDH levels. (C-D) JWF2 cells 
were treated with vehicle (ETOH), H2O2 (50µM), AEA (10 and 20 µM) and 15-deoxyPGJ2 
(5µM, positive control) for 1 hour. (C) Oxidative stress was measured by flow cytometry using 
CM-H2DCFDA reagent. Fluorescence was measured as a percent increase from control untreated 
cells. (D) The intracellular level of total glutathione was measured using DTNB reagent. Data 
were analyzed using one way ANOVA followed by Tukey’s multiple comparison test and are 
represented as mean ± SEM (* indicates the statistically significant difference between the 
samples and vehicle treated cells, P<0.05). (E-F) JWF2 cells were pretreated with CM-
H2DCFDA and then treated with vehicle (ETOH) or 20 µM AEA for 1 hour. DCF fluorescence 
(E, upper panel) and phosphorylated eIF2α (F, upper panel) were measured using flow cytometry 
and analyzed with a BD FACSCanto II flowcytometer with BD FACSdiva software (BD 
Biosciences). Red peaks correspond to AEA treated cells and black peaks correspond to vehicle 
treated cells. Mean fluorescence intensities in AEA and vehicle treated cells were represented as 
mean ± SEM (E-F, lower panels). Data were analyzed using Student’s t-test (* indicates the 
statistically significant difference between AEA and vehicle treated cells, P<0.05).         
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Figure 4.2: Antioxidants inhibited AEA-induced oxidative stress and cell death 
(A-B) NAC inhibited AEA-induced oxidative stress and GSH reduction. JWF2 cells were 
pretreated with NAC (25 or 50 mM) for 2 hours and then treated with AEA (20 µM) for 1 hour. 
(A) Oxidative stress was evaluated by flow cytometry using CM-H2DCFDA reagent. DCF 
fluorescence was measured as a percent increase from control untreated cells. (B) Intracellular 
total glutathione level was measured using DTNB reagent. (C-D) Trolox inhibited AEA-induced 
oxidative stress but not GSH reduction. JWF2 cells were pretreated with Trolox (0.25 or 0.5 
mM) for 1 hour and then treated with AEA (20 µM) for 1 hour. (C) Oxidative stress was 
evaluated by flow cytometry using CM-H2DCFDA reagent. DCF fluorescence was measured as 
a percent increase from control untreated cells. (D) Intracellular total glutathione level was 
measured using DTNB reagent. (E-F) NAC and Trolox inhibited the antiproliferative effect of 
AEA. JWF2 cells were pretreated with NAC (25 or 50 mM) for 2 hours (E) or Trolox (0.25 or 
0.5 mM) for 1 hour (F) and then treated with AEA (20 µM) for 8 hours. Cell viability was 
measured using MTS assay. Data were analyzed using one way ANOVA followed by Tukey’s 
multiple comparison test and are represented as mean ± SEM (* indicates the statistically 
significant difference between the samples and vehicle-treated cells. # indicates the statistically 
significant difference between the samples and AEA-treated cells. P<0.05).  
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Figure 4.3: Oxidative stress is required for the initiation of ER stress-apoptosis by AEA 
JWF2 cells were pretreated with 0.5mM Trolox for 1 hour and then treated with AEA. (A) 
CHOP 10 expression (4 hours), (B) Cleaved Caspase 3 (Cl-Casp3) (6 hours) and GAPDH 
expressions (loading control) were analyzed by Western blot analysis. Band intensities were 
quantified using ImageJ software.  Fold induction in protein expression was determined by 
comparing the band intensities of samples to vehicle-treated cells after normalizing GAPDH 
levels. 
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Figure 4.4: The apoptotic effect of AEA on NMSC was not mediated by cannabinoid 
receptors  
(A) Selective CB1 (AM251) and CB2 (AM630) receptors antagonists inhibited the effect of 
AEA on the reduction of cAMP. JWF2 cells were pre-treated with the indicated concentrations 
of AM251 and AM630 for one hour and then treated with 20µM AEA for 15 minutes. cAMP 
was measured using the cAMP Glo ELISA kit. (B-D) AEA-induced apoptotic cell death was not 
mediated by CB1or CB2 receptors. JWF2 cells were pretreated with 0.1 mM AM251 or AM630 
and then treated with vehicle (ETOH), or AEA (20 µM) for 4 and 8 hours. (B, C) Caspase 3 
cleavage and GAPDH (loading control) were analyzed by Western blot. Fold induction in protein 
expression was determined by comparing the band intensities of samples to vehicle-treated cells. 
(D) Cell viability was measured after 8 hours by MTS assay. Data were analyzed using one way 
ANOVA followed by Tukey’s multiple comparison test and are represented as mean ± SEM (* 
indicates the statistically significant difference between the samples and vehicle treated cells and 
# indicates the statistically significant difference between the samples and AEA- treated cells, 
P<0.05). 
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Figure 4.5: Oxidative and endoplasmic reticulum stress induced by AEA was not mediated 
by cannabinoid receptors 
(A, B) AEA-induced oxidative stress was not mediated by cannabinoid receptors CB1/2. JWF2 
cells were pre-treated with 0.1 mM AM251 (A) or 0.1 mM AM630 (B) for one hour and then 
treated with 20 µM AEA for 1 hour. Oxidative stress was measured as a percent increase in DCF 
fluorescence from untreated cells. Data were analyzed using one way ANOVA followed by 
Tukey’s multiple comparison test and are represented as mean ± SEM (* indicates the 
statistically significant difference between the samples and vehicle treated cells and # indicates 
the statistically significant difference between the samples and AEA- treated cells, P<0.05). (C, 
D) AEA-induced ER stress was not mediated by CB1/2 receptors. JWF2 cells were pretreated 
with 0.1 mM AM251 or AM630 and then treated with vehicle (ETOH), or AEA (20 µM) for 4 
hours. CHOP 10 and GAPDH expression (loading control) were analyzed by Western blot. Fold 
induction in protein expression was determined by comparing the band intensities of samples to 
vehicle-treated cells.   
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4.6. DISCUSSION 
Non melanoma skin cancer (NMSC) is the most common cancer in the United States. 
NMSC is associated with substantial annual health care costs, which are expected to rise 
dramatically due to excessive sun and UV-light exposure (Diepgen and Mahler, 2002;Guy and 
Ekwueme, 2011). Accordingly, novel treatments are required to address this issue. The 
endocannabinoid, AEA, is a potential therapeutic for NMSC. In chapter three, we showed that 
AEA selectively induced ER stress-mediated apoptosis in NMSC cells that overexpress COX-2 
(Soliman et al., 2014). Specifically, we demonstrated that the cytotoxic effects of AEA were 
most likely produced by the novel prostaglandin, 15d-PGJ2-EA, which was synthesized as a 
consequence of the metabolism of AEA by COX-2.  In this Chapter, we demonstrate that AEA-
induced ER stress-apoptosis was also regulated by oxidative stress that was partially mediated by 
a reduction in total GSH levels.  In contrast, cannabinoid receptor activation was not required for 
oxidative stress, ER stress or apoptosis that was caused by AEA.  Thus, cell death in NMSC cells 
is likely regulated by the conversion of AEA to 15d-PGJ2-EA, which diminishes intracellular 
glutathione levels leading to oxidative stress, ER stress and ultimately apoptosis (Figure 4.6). 
Oxidative stress plays an important role in the promotion and prevention of 
carcinogenesis.  Relatively high levels of reactive molecules are required to activate proliferative 
and pro-survival signal transduction pathways while; excessive oxidative stress causes sufficient 
damage to cellular DNA, proteins and lipids to activate cell death pathways (Glasauer and 
Chandel, 2014). Thus, a therapeutic strategy that has been employed to elicit tumor cell death is 
to utilize agents that induce excessive oxidative stress. Several clinically available anticancer 
agents including doxorubicin and bleomycin induce tumor cell death by initiating lethal 
oxidative stress (Burger et al., 1981;Thorn et al., 2011).  However, additional studies are needed 
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to fully characterize the oxidative properties of AEA and the role of oxidative stress in AEA-
induced tumor cell death.  It has been reported that AEA-induced cell death was prevented by the 
antioxidants, NAC, GSH, and ebselen in head and neck squamous cell carcinoma cells (Park et 
al., 2014).  In addition, we showed previously that inhibiting the generation of oxidative stress 
with NAC blocked AEA-mediated apoptosis in tumorigenic keratinocytes.  In this study, we 
report that oxidative stress was also required for ER stress-mediated apoptosis (Figure 4.3).  In 
addition, our data suggested that AEA-induced oxidative stress was caused by a reduction in the 
intracellular glutathione levels.  In most cells, glutathione is the primary antioxidant that 
neutralizes reactive oxygen/nitrogen species and electrophilic molecules (Ribas et al., 2014).  
Diminished glutathione levels weaken the cell’s defense against reactive molecules leading to 
excessive oxidative stress and cell death.  Consistent with these observations, Siegmund et al. 
demonstrated that the susceptibility of hepatic stellate cells to AEA-induced cell death correlated 
with the cellular GSH content with high levels of GSH conferring resistance and low levels 
promoting sensitivity to cell death (Siegmund et al., 2005;Siegmund et al., 2006).  Interestingly, 
a different study showed that GSH also regulated J-series prostaglandin-induced cell death 
(Kondo et al., 2001). 15d-PGJ2 is a cyclopentenone prostaglandin that possesses a highly reactive 
α, β- unsaturated carbonyl group in its cyclopentenone ring, which can interact via a Michael 
addition reaction with nucleophiles including free sulfhydryls of cysteine residues in cellular 
proteins.  Covalent binding of J-series PGs with GSH and other proteins that regulate cellular 
redox status inactivate these antioxidant enzymes thereby increasing ROS (Uchida and Shibata, 
2008).  Since AEA is metabolized to 15d-PGJ2-EA, which possesses the conserved α, β- 
unsaturated carbonyl group, it is highly probable that 15d-PGJ2-EA also binds to and reduces 
GSH levels in AEA-treated cells. Hence, our supposition that a reduction in intracellular 
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glutathione is involved in the initiation of lethal oxidative stress in AEA-treated cells is 
consistent with our presented data and the established prooxidant activity of the J-series 
prostaglandins. 
Although our data indicate that the activity of AEA/15d-PGJ2-EA appears to be 
controlled primarily by GSH, AEA-mediated ER stress-apoptosis may also be regulated by 
oxidative stress.  NAC is a thiol antioxidant which serves as a prodrug to L-cysteine, the limiting 
agent in GSH synthesis (Zafarullah et al., 2003).  Trolox, on the other hand, is an antioxidant 
which acts primarily by scavenging the free radicals (Mazor et al., 2006).  In Figure (4.2) we 
demonstrated that Trolox and NAC inhibited AEA-induced oxidative stress and cell death 
however, cell treatment with NAC but not Trolox produced a complete restoration of GSH 
levels. This suggests that since the cells were rescued from cell death by an antioxidant that 
primarily scavenges free radicals that ROS may also be a key initiator of oxidative stress. This 
idea is supported by Kondo et al who demonstrated that 15d-PGJ2 increased the generation of the 
highly reactive molecules, 4-hydroxy-2-nonenal (HNE) and acrolein, and also decreased the 
transient mitochondrial membrane potential (Kondo et al., 2001). Thus, cytotoxic oxidative 
stress generated by AEA is likely caused by multiple mechanisms including the modulation 
antioxidant enzyme levels and the production of reactive cellular molecules.  
Reactive oxygen species (ROS) have emerged as important regulators of physiological 
ER activity as well as initiators of ER stress. Although the molecular events linking ROS to 
components of the ER stress pathway are still obscure, evidence connecting these distinct 
processes is increasing. For example, in several diseased conditions, ER stress and increased 
ROS production occur concurrently (Malhotra and Kaufman, 2007). In addition, Verfaillie et al 
reported that PERK, which is a key mediator of ER stress signaling, is located at the ER-
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mitochondria contact sites and is required to induce apoptosis after oxidative stress-dependent 
ER stress (Verfaillie et al., 2012). Consistent with these findings our data show that the 
antioxidant Trolox inhibited AEA-induced CHOP 10 expression and caspase 3 cleavage (Figure 
4.3) indicating that ROS production is important for ER stress-apoptosis.  Similarly, Su and 
associates showed that ROS was required for ER stress and apoptosis in cells treated with15d-
PGJ2 (Su et al., 2008).  Collectively, these findings suggest that the induction of oxidative stress 
by AEA likely leads to the activation ER stress and the initiation of apoptosis.  
Several in vivo and in vitro studies have reported that cannabinoid-induced cell death 
occurs via CB1/2 receptor-dependent and -independent pathways (Van Dross R. et al., 2013). 
For example, CB1 receptors were reported to mediate ER stress-apoptosis induced by AEA in 
neuroblastoma cells (Pasquariello et al., 2009) and by tetrahydrocannabinol (THC) in glioma 
cells (Salazar et al., 2009). Furthermore, in hyperplastic cholangiocytes, AEA-induced apoptosis 
required CB2 receptor-dependent activation of thioredoxin 1/ redox factor 1and AP1 (DeMorrow 
et al., 2007). In contrast, CB1- and CB2-independent cell death has also been observed in several 
reports. The use of CB1 and CB2 receptor antagonists did not inhibit AEA-induced cell death in 
human colorectal cancer cells (Gustafsson et al., 2009;Patsos et al., 2010). In addition, AEA-
induced cell death was initiated independent of CB1, CB2 and the endocannabinoid-sensitive ion 
channel, TRPV1 in tumorigenic keratinocytes (Kuc et al., 2012).  In the current study, we 
observed that pharmacological antagonism of the CB1 and CB2 receptors did not inhibit AEA-
induced oxidative stress, ER stress or apoptosis in NMSC cells (Figure 4.4-4.5). Since we also 
demonstrated that cannabinoid receptor levels were not modulated by cell exposure to AEA (Kuc 
et al., 2012), it is unlikely that the inability of CB1/2 antagonist to inhibit the cytotoxicity of 
AEA was due to the down regulation of these receptors.   
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Collectively, these findings show that oxidative stress is required for AEA-induced ER 
stress and apoptosis.  Furthermore, our findings indicate that although AEA is a cannabinoid 
receptor agonist, the cytotoxicity of this agent is not reliant on these receptors. Hence, one can 
reasonably conclude that AEA is metabolized to 15d-PGJ2-EA, which initiates oxidative stress 
and triggers ER stress-mediated apoptosis.   
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Figure 4.6: Proposed pathway of AEA-induced apoptosis in NMSC cells 
We propose that in tumor cells which overexpress COX-2, AEA is metabolized by COX-2 
followed by prostaglandin D synthase (PGDS) to ethanolamide conjugated J-series 
prostaglandins that decrease total intracellular Glutathione (GSH) thereby increasing the 
sensitivity of the cells to oxidative stress. The induction of oxidative stress then leads to ER 
stress, which then causes apoptosis. The effects of AEA on oxidative stress, ER stress, and 
apoptosis are not mediated by CB1 or CB2 receptors.  
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CHAPTER FIVE: GENERAL DISCUSSION AND SUMMARY 
The main goal of the present study was to develop a novel therapeutic for NMSC that is 
selectively toxic to cancer cells but has minimal toxicity in the normal surrounding cells. To 
achieve this goal, we took advantage of the fact that COX-2 is overexpressed in tumor, but not in 
non-tumor, cells (Figure 3.1B).  COX-2 metabolizes AEA to PGD2-EA, PGE2-EA and PGF2α-
EA (Kozak et al., 2002a).  Our data provided the first evidence that AEA is also converted to the 
cytotoxic J- series prostaglandin-ethanolamide, 15d-PGJ2-EA (Figure 3.6). Therefore, we 
hypothesized that AEA would be metabolized to 15dPGJ2-EA in tumor cells that overexpress 
COX-2 but not normal keratinocytes, which contain low endogenous levels of COX-2. Indeed, 
our data showed that AEA preferentially inhibited the survival of tumorigenic JWF2, but not 
non-tumorigenic HaCaT keratinocytes (Figure 3.1A). Furthermore, we observed that the 
antiproliferative effect of AEA correlated with the magnitude of COX-2 expression (Figure 3.2) 
suggesting that this enzyme plays a crucial role in AEA cytotoxicity.  Hence, the main objectives 
of the present study were to determine whether the cytotoxicity of AEA was mediated by 15d-
PGJ2-EA and to uncover molecular mechanisms by which AEA-induced apoptosis occurs.  
In the first part of this study, we confirmed our previous finding that AEA induced 
NMSC cell apoptosis (Figure 3.4). We also determined that AEA caused ER stress as indicated 
by the activation of PERK, ATF6, and IRE1 signaling pathways (Figure 3.3). In addition, the ER 
stress-associated pro-apoptotic proteins CHOP10 and caspase 12 were activated prior to the 
initiation of apoptosis (Figure 3.4).  Moreover, ER stress was necessary for the induction of 
apoptosis by AEA (Figure 3.5). The role of COX-2 in AEA-induced ER stress-apoptosis was 
also examined and it was determined that COX-2 was required for ER stress in the presence of 
AEA (Figure 3.7 and 3.8). Collectively, these data suggested that COX-2 regulated AEA-
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mediated ER stress-apoptosis by converting AEA to 15d-PGJ2-EA. In support of this contention, 
several studies show that AEA and other cannabinoids induce cytotoxic ER stress in cancer cells 
(Carracedo et al., 2006;Pasquariello et al., 2009). In addition, J-series prostaglandins, which are 
derived from AA initiate apoptosis via the ER stress pathway (Su et al., 2008). Thus, AEA-
induced ER stress-apoptosis is likely mediated by 15d-PGJ2-EA.  
To establish the requirement for 15d-PGJ2-EA in AEA-induced cell death, the synthesis 
of D- and J-series PGs was blocked using a selective inhibitor of PGDS.  Blockade of PGDS 
activity prevented AEA-induced ER stress and apoptosis (Figure 3.9E). Moreover, exogenous 
PGD2-EA was converted to J-series prostamides and also induced ER stress-apoptosis (Figure 
3.10). Other reports have shown that COX-2 was necessary for AEA-induced tumor cell death 
(Ramer et al., 2001;Patsos et al., 2010). However, our data provided the first evidence that AEA-
induced apoptosis was due to the production of 15d-PGJ2-EA.  
In the second part of this study we sought to determine: 1) the role of oxidative stress in 
AEA-induced ER stress-apoptosis, and 2) the role of the cannabinoid receptors in oxidative 
stress, ER stress and apoptosis. Our data indicated that a reduction in intracellular GSH and an 
increase in intracellular ROS were the most likely causes of AEA-induced oxidative stress 
(Figure 4.1). We also determined that antioxidants could prevent AEA-mediated oxidative stress 
and apoptosis. Furthermore, an antioxidant blocked AEA-initiated ER stress suggesting that 
oxidative stress was required for AEA-induced ER stress-apoptosis.  Consistent with these 
results, Gustafson et al showed that AEA-induced apoptosis occurred in an oxidative stress-
dependent fashion in colorectal carcinoma cells (Gustafsson et al., 2009). In addition, ROS 
production induced by 15d-PGJ2 was caused by the interaction of 15d-PGJ2 with GSH (Kondo et 
al., 2001;Uchida and Shibata, 2008). Furthermore, 15d-PGJ2-induced ROS was shown to 
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regulate ER stress and apoptosis (Su et al., 2008). Thus, the generation of oxidative stress is 
essential for the induction of ER stress-mediated apoptosis in tumor cells that are treated with 
AEA.   
The data presented in this study also firmly establish that AEA-induced apoptosis does 
not require the activity of the cannabinoid receptors. Specifically, we demonstrated that selective 
antagonism of the CB1 or CB2 receptors did not inhibit AEA-induced oxidative stress, ER stress, 
or apoptosis (Figure 4.4 and 4.5). In agreement of these observations, CB1 and CB2 receptor 
antagonists did not inhibit AEA-induced cell death in human colorectal cancer cells (Gustafsson 
et al., 2009;Patsos et al., 2010). Thus, the present findings indicate that although AEA is a 
cannabinoid receptor agonist, the cytotoxicity of this agent does not require these receptors. 
In summary, the data presented in this report show that AEA is cytotoxic to cells that 
overexpress COX-2. We have identified novel, 15d-PGJ2-EA, as a likely regulator of AEA-
mediated tumor cell apoptosis, which our data suggests occurs via the initiation of oxidative 
stress and ER stress in a cannabinoid receptor-independent manner. Since non-tumorigenic 
keratinocytes possess low endogenous levels of COX-2, 15d-PGJ2-EA is not synthesized and 
minimal toxicity occurs in these cells.  As such, AEA and AEA derivatives may be ideal agents 
for topical treatment of NMSC and other cancers that overexpress COX-2. 
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FUTURE DIRECTIONS 
The widely used pharmacological treatment for NMSC is 5-fluorouracil (5-FU). 5-FU 
induces cell cycle arrest and apoptosis by blocking DNA synthesis in rapidly dividing cancer 
cells. Since normal healthy skin cells also divide rapidly, they are subject to 5-FU cytotoxicity. 
Our in vitro findings suggest that AEA is preferentially cytotoxic to tumorigenic compared to 
non-tumorigenic keratinocytes. We also demonstrated that the tumor cell toxicity of AEA is 
attributed to COX-2 and the production of the cytotoxic metabolite, 15dPGJ2-EA. Therefore, 
future investigations will assess the antitumor activity of AEA in vivo. In these studies, the 
xenograft tumor model will be used to evaluate the anticancer activity of AEA. COX-2 
overexpressing cells will be implanted subcutaneously in the flank region of mice and AEA will 
be injected into the tumor to examine its effect on tumor growth. Also, the synthesis of 15dPGJ2-
EA as well as the induction of oxidative stress, ER stress and apoptosis will be evaluated in the 
tumors.  Additional studies will be conducted to examine the safety and pharmacokinetic activity 
of AEA when topically applied to normal mouse skin. Such an investigation will unveil the 
chemotherapeutic properties of AEA against NMSC.  
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